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Abstract
The innate immune system is the first line of host defense, and its ability to propagate
antimicrobial and inflammatory signals from the cellular microenvironment to the tissue at-large
is critical for survival. In a remarkably complex microenvironment, cells are constantly
processing external cues, initiating convoluted intracellular signaling cascades, and interacting
with neighboring cells to generate a global, unified response. At the onset of infection or sterile
injury, individual cells sense danger or damage signals and elicit innate immune responses that
spread from the challenged cells to surrounding cells, thereby establishing an overall
inflammatory state. However, little is known about how these dynamic spatiotemporal responses
unfold. Through the use GFP reporters, in vitro transplant coculture systems, and in vivo models
of infection and sterile injury, this thesis describes identification of a gap junction intercellular
communication pathway for amplifying immune and inflammatory responses, and demonstrates
its importance in host innate immunity.
The first section describes development of stable GFP reporters to study the
spatiotemporal activation patterns of two key transcription factors in inflammation and innate
immunity: Nuclear factor-KappaB (NFKB) and Interferon regulatory factor 3 (IRF3). Stimulation
of NFKB-GFP reporters resulted in a spatially homogeneous pattern of activation, found to be
largely mediated by paracrine action of the proinflammatory cytokine TNFa. In contrast, the
activation of IRF3 was spatially heterogeneous, resulting in the formation of multicellular
colonies of activated cells in an otherwise latent background. This pattern of activation was
demonstrated to be dependent on cell-cell contact mediated communication between
neighboring cells, and not on paracrine signaling.
The second section describes the discovery of a gap junction intercellular communication
pathway responsible for the formation of IRF3 active colonies in response to immune activation.
Cell sorting and gene expression profiling revealed that the activated reporter colonies,
collectively, serve as the major source of critical antimicrobial and inflammatory cytokines. Using
in vitro transplant coculture systems, colony formation was found to be dependent on gap
junction communication. Blocking gap junctions with genetic specificity severely compromised
the innate immune system's ability to mount antiviral and inflammatory responses.
The third section illustrates an application of the gap junction-induced amplification of
innate immunity phenomenon in an animal model of sterile injury. Drug-induced liver injury was
shown to be dependent on gap junction communication for amplifying sterile inflammatory
signals. Mice deficient in hepatic gap junction protein connexin 32 (Cx32) were protected
against liver damage, inflammation, and death in response to hepatotoxic drugs.
Coadministration of a selective pharmacologic Cx32 inhibitor with hepatotoxic drugs significantly
limited hepatocyte damage and sterile inflammation, and completely abrogated mortality. These
finds suggests that coformulation of gap junction inhibitors with hepatotoxic drugs may prevent
liver failure in humans, and potentially limit other forms of sterile injury.
In summary, this thesis demonstrates the development of novel tools for investigating the
spatiotemporal dynamics of cellular responses, describes how these tools were utilized to
discover a basic gap junction communication pathway critical in innate immunity, and provides
evidence for the clinical relevance of this pathway in sterile inflammatory injury.
Thesis supervisor: Martin L. Yarmush
Title: Helen Andrus Benedict Professor of Surgery and Bioengineering
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Chapter 1
Introduction
1.1 Introduction
This thesis describes the identification of novel gap junction communication pathway for
amplifying immune and inflammatory responses triggered by activation of the innate immune
system. Through the use of green fluorescent protein (GFP) reporters, in vitro transplant
coculture systems, and in vivo models of infection and sterile injury, we attempted to bridge the
gap between basic discovery, at the cellular level, and application at the level of animal models.
The first section describes the development of stable GFP reporters to study the spatiotemporal
activation patterns of two key transcription factors in inflammation and innate immunity: Nuclear
factor-KappaB (NFKB) and Interferon regulatory factor 3 (IRF3). Stimulation of NFkB-GFP
reporters resulted in a spatially homogeneous pattern of activation, found to be largely mediated
by the paracrine action of proinflammatory cytokine tumor necrosis factor (TNFat). In contrast,
the activation of IRF3 was spatially heterogeneous, leading to the formation of multicellular
colonies in an otherwise dark background of non-activated cells. The second section describes
the discovery of a gap junction intercellular communication pathway necessary for the formation
of these IRF3 active colonies of cells that collectively expressed more than 95% of critical
secreted cytokines, including interferon P (IFNp) and TNFa. Blocking gap junctions, with genetic
specificity, limited the secretion of IFNs and TNFa and the corresponding antiviral and
inflammatory state. The third section demonstrates an application of the gap junction
communication phenomenon in an animal model of sterile injury. Drug-induced liver injury was
shown to be dependent on gap junction communication for amplifying sterile inflammatory
signals. Mice deficient in hepatic gap junction protein connexin 32 (Cx32) were protected
against liver damage, inflammation, and death in response to hepatotoxic drug-induced injury.
Coadministration of a selective pharmacologic Cx32 inhibitor with the hepatotoxic drugs
significantly limited hepatocyte damage and sterile inflammation, and completely abrogated
mortality, confirming the importance of hepatic gap junction communication in amplifying sterile
injury and providing a potential novel therapeutic strategy for preventing drug hepatotoxicity.
This chapter begins with motivation for the thesis, followed by a review of relevant
background literature, and finally concludes with an organizational overview of the thesis.
1.2 Motivation
The cellular microenvironment within a tissue is remarkably complex, and is characterized
by an intricate geometry, with unique structural and physicochemical properties, and by cellular
heterogeneity, with various parenchymal and stromal cells forming homotypic and heterotypic
interactions [1, 2]. Within their local surroundings, cells are constantly processing external cues,
and initiating complex intracellular signal transduction cascades to modulate their gene
expression profile and ultimately their phenotype. In an effort to ensure a desired outcome,
activated cells communicate with neighboring cells by propagating signals and recruiting them
to generate an amplified overall tissue wide response [3]. These intercellular communication
pathways are dynamic, both in space and time, and involve multiple modes of signaling
including the paracrine action of soluble secreted factors and cell-contact mediated
communication.
In the case of infection or injury, the ability of the innate immune system to propagate
antimicrobial and inflammatory signals from the local cellular microenvironment to the tissue at-
large becomes critical for survival [4]. At the onset of an infection or injury, individual cells sense
danger or damage signals and elicit innate immune responses that spread from the challenged
cells to surrounding naYve cells, thereby establishing an overall inflammatory state [5]. However
little is known about how these complex spatiotemporal responses unfold. It is well documented
that the secretion of antimicrobial cytokines, such as type I interferons, from infected cells is
pivotal for establishing immunity [6, 7, 8]. Similarly, it has also been shown that the secretion of
proinflammatory cytokines, such as TNFa, interleukin 1 beta (IL p), and interleukin 6 (1L6), is
essential for creating an inflammatory state to infection or sterile injury [9, 10, 11, 12, 13].
Cytokines secreted from initially challenged cells activate surrounding cells, priming them to
resist further infection or injury. They also function to recruit innate immune cells, such as
neutrophils and monocytes, to combat invading pathogens or to begin the process of tissue
repair. While the overall importance of paracrine-mediated intercellular communication cannot
be denied for amplifying immune and inflammatory responses, the spatiotemporal details
remain speculative, and the possibility of cell contact-mediated communication in innate
immunity unexplored.
Compared to amplification by secreted cytokines, contact-dependent signaling is faster and
spatially localized, and therefore better suited for anticipating and preventing the rapid spread of
infection or sterile injury [14]. Cell-cell contact mediated communication has been shown to
greatly influence cellular responses during inflammatory and infectious conditions [15, 16, 17,
18, 19, 20]. In the liver, direct contact between parenchymal hepatocytes and stromal kupffer
cells amplifies the robust production of proinflammatory cytokines during endotoxin shock, and
plays a pivotal role in the development of fulminate hepatic failure [15]. Similarly, cell-contact
mediated signaling in both airway epithelial cells and alveolar endothelial cells has been shown
to amplify innate immune and inflammatory responses to infection prior to the involvement of
secreted cytokines [18, 20, 21]. Given the significance of contact-mediated intercellular
communication in intensifying immune responses to infection or injury, an urgent need exists for
investigating the underlying molecular mechanisms. These investigations may implicate new
signaling pathways to target for limiting injury at the cellular level, before it gets propagated to
the tissue at-large and causes organ dysfunction and systemic disease. In the case of infection,
these pathways can be upregulated to further increase immune amplification for ensuring
pathogen eradication and immunity. However, in the case of sterile injury these pathways can
be inhibited to prevent host damage and disease progression.
1.3 Background
1.3.1 The Innate Immune System
The integrated human immune system is divided into of two branches: innate and adaptive
(or acquired) immunity [22]. The innate immune system includes all aspects of host immune
defense mechanisms that are encoded by germline genes [23]. These include physical barriers,
such as epithelial cell and mucosal layers, soluble proteins that are either constitutively present
(such as the complement proteins, defensins, and ficolins) or that are released from activated
cells (including cytokines that regulate the function of other cells, chemokines that attract
inflammatory leukocytes, lipid mediators of inflammation, and reactive free radicals that also
contribute to tissue inflammation) [24, 25, 26, 27]. Additionally, the innate immune system relies
on a limited repertoire of receptors, including membrane-bound receptors and cytoplasmic
proteins that detect invading microbes by binding pathogen-associated molecular patterns
(PAMPs), and host injury by binding endogenous damage-associated molecular patterns
(DAMPs) [28, 29, 30, 31].
The innate immune system is the first line of host defense against pathogens and is
mediated by nonhematopoietic cells as well as specialized hematopoietic cells including
macrophages and dendritic cells [23, 24]. In contrast to the adaptive immune system, which
depends on T and B lymphocytes, innate immune protection is a task performed by cells of both
hematopoietic and nonhematopoietic origin [23]. Hematopoietic cells involved in innate immune
responses include macrophages, dendritic cells, mast cells, neutrophils, eosinophils, natural
killer (NK) cells, and NK T cells [23]. In addition to these hematopoietic cells, innate immune
responsiveness is a property of epithelial and endothelial cells alike.
Speed is a defining characteristic of the innate immune system. Within minutes of pathogen
exposure or sterile injury, the innate immune system is activated and begins generating an
antiviral and inflammatory response [32, 33]. Moreover, innate immunity plays a central role in
activating the subsequent adaptive immune response (Fig. 1) [32, 33]. The adaptive immune
system is involved in eliminating pathogens during the late phase of infection, as well as
generating immunological memory [34]. In contrast to the limited number of pathogen receptors
used by the innate immune system, the adaptive immune system boasts an extremely diverse,
randomly generated repertoire of receptors by clonal selection of lymphocytes developed due to
gene rearrangements [34].
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Figure 1. Functions of the Innate Immune System. Innate immune cells sense invading pathogens and
trigger proinflammatory and antiviral reactions. The activated dendritic cells also upregulate co-
stimulatory molecules and MVHC molecules for secondary activation of the acquired immune system.
1.3.2 The Intracellular SiQnalin-Q Pathways of Innate Immunity
The innate immune system utilizes an array of germlIine-encoded receptors for recognizing
microbial PAMPs during infection and host DAMPs during sterile injury [28, 29, 30, 31]. Upon
detection, these receptors engage adaptor molecules and initiate complex intracellular signaling
cascades which ultimately results in the activation of NFKb, IRF3, and other transcription
. .. . ........ ..  ............ ..... .  . .  ......... .... . . ..... . ...
factors, for driving the production of proinflammatory cytokines and other immunologic
responses (Fig. 2) [35, 36, 37, 38]. These signaling cascades involve multiple Toll like receptor
(TLR) pathways for detecting extracellular stimuli, and nucleotide oligomerization domain
(NOD)-like receptor (NLR) pathways for sensing cystolic stimuli. During infection, the innate
immune system uses pattern recognition receptors (PRRs) to detect "microbial nonself" ligands,
such as LPS, double stranded RNA, CpG DNA, and viral DNA [28]. In sterile injury conditions,
the innate immune system uses these PRRs to detect immunologic danger in the form of
DAMPs. DAMPs represent common intracellular host molecules that are normally
immunologically inert, but become active when released during cell damage and tissue injury.
Well-characterized DAMPs include high mobility group box 1 (HMGB1), uric acid, and host DNA
[30, 31].
UR4
Figure 2. Sensing and Signaling in the Innate Immune System. Cells sense infection or injury-
associated stimuli through the use of germline encoded receptors, and initiate signaling pathways for the
activation of proinflammatory and innate immune transcription factors (http://www.umassmed.edu/igp/-
faculty/fitzgerald.cfm).
1.3.3 Innate Immune Sensing of DNA
The innate immune system senses nucleic acids during infection or tissue damage[39, 40,
41, 42]. Pathogen-derived nucleic acids generate potent immune responses, as they are not
...... . .... ........... 
typically found in a host cell or in particular intracellular locations [43, 44]. DNA in pathogens or
host cells in normally hidden from the immune system as it is tightly sequestered within the
nuclear or mitochondrial membrane in eukaryotes, the cell wall in bacteria, or the envelope in
viruses. However, following infection or sterile tissue injury, DNA is released into sub-cellular
compartments where it becomes an active immunostimulatory molecule [33, 39]. Double
stranded DNA (dsDNA) derived from host, viral, bacterial, or synthetic sources, elicits a potent
innate immune response [43]. CpG-rich DNA from bacteria stimulates immune responses by
activating the endosomal DNA-sensing TLR9 [45]. Following CpG DNA detection by TLR9, the
adaptor molecule MyD88 (myeloid differentiation primary response gene 88) associates with the
intracellular domain of TLR9, signaling for the activation of transcription factor IRF5 (interferon
regulatory factor 5), IRF7 (interferon regulatory factor 7), NFKB, and the MAP (mitogen-
activated protein) kinase pathway, resulting in the production of proinflammatory cytokines and
type I interferons (Fig. 3) [45].
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Figure 3. Innate Immune Recognition of DNA. In infection and/or sterile tissue damage, DNA is
exposed to DNA-sensing PRRs. DNA is sensed by the innate immune system in a TLR9-dependent or
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independent manner. The TLR9 pathway senses CpG-rich DNA, commonly found in bacterial genomic
DNA, in the endosomal compartment of host cells, activating the production of interferons and
proinflammatory cytokines. The TLR-independent pathway senses dsDNA in the cytosol of host cells,
through a yet unidentified sensor, and activates transcription factors IRF3 and NFKB for the production of
IFNp and proinflammatory cytokines (figure adapted from Ishii et al [43]).
Other sources of non-CpG dsDNA, including host, viral, and synthetic, promote an immune
response by activating an unidentified TLR-independent cytosolic DNA sensor in a sequence-
independent manner [17, 46, 47, 48]. This cytosolic dsDNA sensor is activated when dsDNA is
introduced into the cytoplasm of cells, possibly released from intracellular pathogens such as
DNA viruses and certain bacteria, or from damaged host cells. The TLR-independent pathway
for dsDNA sensing activates TBK1 and IKKE for the phosphorylation of transcription factor IRF3,
which binds to interferon-sensitive response element (ISRE) sequences, triggering the robust
production of type I interferons such as IFNs [46, 49, 50]. The pathway also activates IKKa and
IKKp for the phosphorylation of NFKB (Fig. 3) [9, 47].
1.3.4 The Local Microenvironment of Infection and Injury
The cellular microenvironment within a tissue is remarkably complex, and is characterized
by an intricate geometry (structural and physicochemical), by cellular heterogeneity (within
parenchymal and stromal cells), and by soluble components [1, 2]. Within their local
surroundings, cells are constantly processing external cues, and initiating complex intracellular
signal transduction cascades to modulate their gene expression profile and ultimately their
phenotype. As a result, cells are modifying their membrane receptor profiles, secreting
cytokines, liberating growth factors, and producing secondary messengers for communicating
signals to their neighboring cells, all in an effort to create a synchronized response to the initial
external cue. These intercellular communication pathways at the cellular level are dynamic, both
in time and space, and exist between multiple cell types, with each cell type playing a unique
and critical role in amplifying a response to the tissue level [3]. In the case of infection or injury,
the ability of the innate immune system to propagate antimicrobial and inflammatory signals
from the local cellular microenvironment to the tissue at-large becomes critical for survival [4].
At the onset of infection or injury, individual cells sense danger or damage signals and elicit
innate immune responses that spread from challenged cells to surrounding unstimulated cells,
thereby establishing an overall inflammatory state [5]. Secreted cytokines such as IFNs, TNFa,
ILP, and IL6 are key mediators of this response [9, 10, 11, 12, 13]. Cytokines are produced
during the activation of innate immunity, and are considered to be the principal means for
intercellular communication of an infection or sterile injury [3]. They serve to propagate the
inflammatory response and define its magnitude, and play a critical role in protecting naive,
neighboring cells from infection or injury. In the case of infection, this response is largely
protective and limits the infectious front. However, in the case of sterile injury (i.e. trauma, drug
induced, ischemia-reperfusion, autoimmune), this response may be pathologic and contribute to
organ dysfunction and disease [51, 52]. While the communication of these responses is
commonly attributed to secreted cytokines, the spatiotemporal details remain speculative, and
the possibility of contact-mediated communication unexplored.
1.3.5 Cell-cell Contact Mediated Communication in Immunology
Cell-cell contact mediated communication has been shown to greatly influence
immunological function during inflammatory and infectious conditions [15, 16, 17, 18, 19, 20]. In
the liver, direct contact between parenchymal hepatocytes and stromal kupffer cells amplifies
the robust production of TNFa in endotoxin shock, and plays a key role in the development of a
fulminating hepatic inflammatory response [15]. This type of heterotypic cell contact mediated
interaction between parenchymal cells and surrounding nonparenchymal neighbors has also
been shown to be critical for maintaining hepatocyte phenotype and preserving organ function
[1]. Additionally, regulator T cells (Tregs) have been shown to suppress and control the immune
regulatory network of effector T cells through a cell-cell contact interaction involving gap junction
mediated transfer of cAMP [16]. Furthermore, Tregs not only modulate ongoing CD4+T cell-
mediated immune reactions at tissue sites but also abrogate the de novo induction of CD8+T
cell-driven immune reactions by interfering with T-cell stimulatory activity of dendritic cells
(DCs) through contact mediated gap junction intercellular communication [16]. Contact-
dependent gap junction communication has also been demonstrated to be key in antigen cross
presentation on DCs and macrophages [19].
1.3.6 Gap Junction Intercellular Communication
Contact-independent signaling is ideal for long-range communication, while contact-
dependent signaling is best suited for spatially localized rapid communication [14]. Gap junction
intercellular communication represents an important class of contact-dependent signaling. Gap
junctions are assemblies of intercellular channels composed of connexin proteins (Cx)
organized into two subsets, alpha connexins (i.e. Cx43) and beta connexins (i.e. Cx32, Cx26).
Connexins from each subset oligomerize to form a hemichannel (Fig. 4) [53]. A functional
channel is formed when a hemichannel from one subset assembles with a hemichannel of the
same subset from an adjacent cell [53]. The resulting gap junctions directly connect the cytosol
of the coupled cells, allowing the exchange of ions, nutrients, and secondary messengers for
the maintenance of tissue homeostasis [54, 55]. In the context of innate immunity, gap junction
communication has been shown to be regulated by pathogen-associated stimuli such as LPS
and peptidoglycans, and secreted proinflammatory cytokines such as TNFa, IL1 P, and IFNy [56,
57]. However, the relative contributions of contact-dependent and contact-independent
communication in the establishment of host defenses have not been explored. Compared to
secreted cytokine amplification, gap junction-mediated signaling is typically faster and therefore
better suited for anticipating and preventing the rapid spread of an invading pathogen [53].
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Figure 4. Structural organization of gap junctions. A gap junction is an assembly of six connexin
molecules, comprising a hemi-channel called connexon that forms a functional channel when it is
connected to a hemi-channel present in the membrane of a neighboring cell. These channels facilitate
passive diffusion of small molecules and peptides involved in a number of processes like cell maturation
and differentiation, apoptotic cell death and cross-presentation. Connexin molecules span the plasma
membrane (pm), which exposes two extracellular loops to the extracellular space. In both extracellular
loops three conserved cysteine residues (blue dots) are present, which are critical for the docking of a
hemi-channel to a hemi-channel in the membrane of an adjacent cell. The large C-terminal cytoplasmic
tail harbors several regulatory sites for phosphorylation (yellow dots) that control the gating of the channel
[58].
1.4 Organizational Overview of Thesis
This thesis is organized into five chapters. Chapter 1 provides motivation and context for the
work. Chapters 2, 3, and 4 are stand alone bodies of work, each linked to the prior through
connections in innate immunity and gap junction communication. Chapter 2 demonstrates that
double stranded DNA, a potent ligand of the innate immune system, induces NFKB and TNFa-
mediated immune responses for endothelial activation and acute inflammation. This work
suggests that endothelial-mediated inflammatory responses play a key role in host defense to
.....................  ........... ----------- . ....... - - -- ..... . . ..  ...... . .. .
DNA from infection or sterile injury. Chapter 3 illustrates that activation of the innate immune
system by dsDNA triggers intercellular communication through a gap junction-dependent
signaling pathway, recruiting colonies of cells to collectively secrete antiviral and inflammatory
cytokines for the propagation of danger signals across the tissue at-large. This work suggests
that gap junction mediated propagation of immune signals lies upstream of the paracrine action
of secreted cytokines, and therefore their modulation may represent a novel therapeutic strategy
for tailoring the innate immune response to infection or injury. Chapter 4 describes an
application of the aforementioned gap junction communication phenomenon in an animal model
of sterile injury. Drug-induced liver injury was shown to be dependent on gap junction
communication for amplifying sterile inflammatory signals. Mice deficient in hepatic gap junction
protein Cx32 were protected against liver damage, inflammation, and death in response to
hepatotoxic drug-induced injury. This work suggests inhibition of hepatic gap junctions as a
viable clinical strategy for preventing drug hepatotoxicity and potentially other forms of sterile
injury. Chapter 5 provides concluding remarks for the thesis.
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Chapter 2
DNA Induces NFKB and TNFa-mediated Innate Immune Responses for Endothelial
Activation and Acute Inflammation
2.1 Summary
The endothelium plays an important role in many pathological conditions. As a barrier
between the vascular space and parenchymal tissue, it can be activated by host DNA released
from damaged cells due to sterile injury or by pathogen DNA exposed to cells during viral
infection. However, little is known about the role endothelial cells play in the inflammatory
response to DNA. Here, we investigated how innate inflammatory responses triggered by DNA
sensing result in endothelial activation and acute inflammation. Direct exposure to DNA induced
activation of NFKB and MAPK pathways in endothelial cells, leading to expression of adhesion
molecules, and leukocyte adhesion to the endothelium. NFKB, JNK, and p38 MAPK were critical
for endothelial activation, as pharmacological inhibition resulted in decreased expression of
adhesion molecules. We further demonstrated that DNA sensing triggers robust secretion of
IRF3 and NFKB-mediated TNFa for sustained secondary activation of the endothelium. Mice
deficient in the TNF receptor were unable to mount an acute inflammatory response to dsDNA.
Our findings identified NFKB and TNFa axis as critical for initiating and amplifying a
proinflammatory response to DNA. Furthermore, this work suggests that endothelial cell-
mediated inflammatory responses play a key role in host defense to DNA from infection or
sterile injury. Blocking these responses in pathological conditions may prevent endothelial
activation and injury, and augmenting during protective situations may reduce infection and
related tissue damage.
2.2 Introduction
The endothelium functions as a key barrier between the intravascular compartment and the
extravascular parenchymal tissues, and is therefore involved in numerous physiological and
pathological processes, such as inflammation [1, 2]. Endothelial cells play a critical role in the
inflammatory process, as they can directly detect various molecular patterns associated with
infection or sterile injury, and trigger an inflammatory response that results in localized leukocyte
recruitment and infiltration at the site of activation [3-5]. Recent investigations have suggested
that double stranded DNA from pathogens or from damaged host cells elicits a potent innate
immune response in endothelial cells that can be protective, leading to immunity, or pathologic,
resulting in amplified sterile injury [6, 7]. This response is comprised of a proinflammatory
component controlled by key alarm cytokines, such as TNFax and IL1P, and an antiviral element
regulated by type I interferons [8]. While the molecular pathways of the interferon response to
DNA have been intensively investigated, little is known about the mechanism of the
inflammatory response triggered by DNA stimulation of the vascular endothelium.
Endothelial cells can detect and respond to DNA directly, or indirectly through the actions of
proinflammatory cytokines. DNA stimulation triggers the robust secretion of proinflammatory
cytokine L1P by activating the inflammasome through the cytosolic DNA sensor absent in
melanoma 2 (AIM2) and the endosomal DNA sensor TLR9 [9, 10]. Both sensors bind DNA, and
associate with inflammasome adaptor molecules for caspase-1 mediated secretion of LlP for
indirectly stimulating the endothelium [6, 9]. Free DNA released from apoptotic cells has also
been shown to directly stimulate endothelial cells to secrete L1p and IL18 [6]. However,
whether this direct detection of DNA is sufficient for inducing endothelial adhesion molecules
and leukocyte recruitment remains unclear, and the role of secondary indirect endothelial
activation by inflammatory cytokines unexplored. Additionally, involvement of endothelial cells in
mediating NFKB and TNFa driven inflammatory signals in response to DNA sensing remains
speculative.
Given the incomplete understanding of the role of endothelial cells in the inflammatory
response to DNA, we investigated the DNA-initiated molecular signaling pathways that lead to
activation of the endothelium. We demonstrated that direct exposure to DNA induced activation
of NFKB and MAPK pathways in endothelial cells. This lead to increased expression of
endothelial adhesion molecules, and resulted in functional leukocyte adhesion to the
endothelium. NFKB, JNK, and p38 MAPK were critical for leukocyte adhesion, since
pharmacological inhibition resulted in decreased expression of adhesion molecules. We further
showed that detection of DNA triggers robust secretion of TNFa for sustained secondary
activation of the endothelium. Both IRF3 and NFKB were required for the production of the
TNFa, and mice deficient in the TNF receptor were unable to mount an acute inflammatory
response to dsDNA. Our findings identify NFKB and TNFa as an alternative innate immune
mechanism to the inflammasome and L1P, capable of initiating and amplifying a
proinflammatory response to DNA. This work suggests the involvement of DNA-induced
endothelial cell immune responses in host defense to infection or sterile injury.
2.3 Results
2.3.1 Endothelial activation and leukocyte adhesion is triqqered by DNA stimulation
Endothelial activation is an early event through which pathogen-associated molecular
patterns induce inflammation during infection and tissue injury. Recent studies have established
the role of DNA as a potent activator of the innate immune system [11]. For evaluating
endothelial activation in response to DNA stimulation, we treated endothelial cells with synthetic
B-form Poly(dA-dT):Poly(dA-dT) (hereafter referred to as DNA) [12]. DNA treatment results in
increased expression of endothelial adhesion molecules ICAM1, VCAM1, and E-selectin (Fig.
1a). The greatest increase in gene expression was observed for VCAM1 (Fig. 1a). Adhesion
molecules play central role in leukocyte recruitment by regulating their attachment to the
endothelium. To determine if DNA stimulation results in increased leukocyte adhesion, confluent
monolayers of endothelial cells were treated with DNA, and then co-cultured with dye-labeled
peripheral blood leukocytes. TNFa stimulated endothelial cells were used as a positive control
for measuring leukocyte adhesion under inflammatory conditions. DNA stimulation of endothelial
cells lead to significantly enhanced binding of leukocytes (3.5 fold), in comparison to the control
(Fig. 1b). Our results indicated that DNA acts as a potent activator of the endothelium by
increasing the expression of adhesion molecules, and directly enhancing leukocyte adhesion to
the endothelium.
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Figure 1. DNA induced activation of the endothelium. (a) Q-PCR for expression of ICAM1, VCAM1,
and E-Selectin in RHMECs after stimulation with DNA (2 ug/ml) for 4 hours. (b) Leukocytes adhesion to
the RHMECs stimulated with DNA (2 ug/ml) or TNFa (10ng/mi) for 12 hours.
2.3.2 DNA induced activation of NFKB and MAPK pathways
NFKB and MAPK pathways are known to play an important role in regulating the expression
of endothelial adhesion molecules [5]. Given that DNA stimulation lead to increased expression
of adhesion molecules, we examined the activation of NFKB and MAPK pathways in response
to DNA. For evaluating NFKB activation, a reporter clone of endothelial cells that synthesizes
GFP in response to NFKB activation was utilized. DNA stimulated NFKB endothelial cell
reporters exhibited elevated levels of GFP in comparison to untreated cells, thereby suggesting
NFKB activation by DNA (Fig. 2a-c). These results were verified by fluorescence microscopy
and flow cytometry (Fig. 2a-c). A nuclear ELISA for NFKB activation further confirmed that DNA
induced dose-dependent activation of NFKB in endothelial cells after 6 hours of stimulation (Fig.
2d). For evaluating activation of MAPKs, phosphorylated protein levels of JNK, p38, and
ERK1/2 were measured in endothelial cells stimulated with DNA for 6 hours. Endothelial cells
treated with DNA showed elevated levels of phosphorylated JNK and p38 in comparison to the
control (Fig. 2e). However, levels of phosphorylated ERK1/2 were similar in both DNA
stimulated and control endothelial cells (Fig. 2e). These results indicated that DNA-mediated
activation of endothelial inflammatory responses include NFKB, JNK and p38 pathways, but not
ERK1/2. a b
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Figure 2. DNA activates NFicB and MAPK pathways in endothelium. (a) and (b) Fluorescence
micrographs of NFKB reporter clone of RHMECs treated with control or DNA (2ug/ml) for 16 hours,
respectively. (c) Fluorescence histogram of reporter clone treated with DNA. (d) ELISA for NFxB activity
in RHMECs stimulated with a dose of DNA (0 to 4 ug/ml) for 6 hours. (e) Phosphorylated protein levels in
RHMECs stimulated with DNA (2 ug/ml) for 6 hours.
2.3.3 Regulation of adhesion molecule expression by modulation of NFKB and MAPK pathways
. ..... ........  .
We next sought to determine whether DNA-mediated activation of NFKB, JNK, and p38 was
required for endothelial activation. Endothelial cells were treated with DNA for 4 hours in the
presence or absence of PDTC, SP600125, or SB202190, known inhibitors of NFKB [13], JNK
[14], and p38 MAPK [15] pathways, respectively. Inhibition of NFKB, JNK, and p38 resulted in
reduced expression of ICAM1, VCAM1, and E-selectin, implying that all three signaling
pathways are involved in DNA stimulated endothelial activation (Fig. 3). Inhibition of NFKB was
most potent at reducing expression of adhesion molecules (Fig. 3). Given that JNK and p38
MAPK are known activators of the AP1 family of transcription factors [16, 17, 18, 19], our results
suggested that transcription factors AP1 and NFKB are required for DNA driven endothelial
activation.
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Figure 3. Inhibitors of NFKB and MAPK pathways modulate adhesion molecule expression in
endothelial cells. Q-PCR for expression of ICAM1, VCAM1, and E-Selectin in RHMECs after stimulation
with DNA (2 ug/ml) for 4 hours in the presence of PDTC(PD), SP600125(SP), or SB202190(SB), which
are inhibitors of NFKB, JNK, and p38 MAPK pathways, respectively.
2.3.4 NFKB and IRF3 mediated TNFa production is critical for sustained secondary activation of
the endothelium
TNFa is an important mediator of innate inflammation, as it acts on vascular endothelial
cells to promote expression of adhesion molecules [20]. Having demonstrated mechanistically
how direct stimulation of endothelial cells with DNA results in the expression of adhesion
molecules, we next sought to investigate whether DNA induced TNFca production. We showed
that DNA stimulation of endothelial cells results in upregulation of TNFa expression and robust
secretion of TNFa into the culture supernatant, as assayed by ELISA (Figure 4a,b). To
determine the transcription factors necessary for TNFa production in response to dsDNA, we
used transgenic knockout mouse embryonic fibroblasts (MEFs). Wildtype MEFs (WT) stimulated
with dsDNA induced significant TNFa secretion after 24 hours (Figure 4c). Conversely, MEFs
deficient in TBK1 and IKKe (TBK1/IKKe DKO), kinases necessary for IRF3 activation, failed to
produce TNFa in response to dsDNA stimulation (Figure 4c). Similarly, dsDNA-stimulated MEFs
deficient in IKKa and IKKb (IKKa/IKKb DKO), kinases essential for NFKB activation, also failed
to produce TNFca (Figure 4c). Together, these data suggest that dsDNA-induced TNFa
secretion is dependent on both IRF3 and NFKB activation.
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Figure 4. DNA mediated TNFa secretion for sustained secondary activation of the endothelium. (a)
Q-PCR for expression of TNFa in RHMECs after stimulation with DNA (1 ug/ml) for 12 hours. (b) ELISA
for TNFa in culture supernatant of RHMECs stimulated with a dose of DNA (.5 to 4 ug/ml) for 24 hours.
(c) ELISA for TNFa in supernatants of wildtype MEFs (WT), TBK1/IKKe DKO MEFs (TBK1/IKKe DKO),
and IKKa/IKKb DKO MEFs (IKKa/lKKb DKO) stimulated with 4 mg/mL of dsDNA for 24 hours. (d) Q-PCR
for expression of VCAM1 in RHMECs stimulated with DNA (1 ug/ml) for 3 or 12 hours, in the presence or
absence of TNFa neutralizing antibody (+ Anti-TNFa) or cycloheximide (+ CHX). (e,f) Representative
fluorescence histograms of Ly-6G expression on peritoneal exudate cells (PEC) in mice injected 16h
earlier with PBS, 2 mg/g of undigested DNA, or 2 mg/g of DNAse digested DNA. The Ly-6G+ gate
represents neutrophils. Neutrophil numbers in PEC of TNFR1+/+ and TNFR1-/- mice 16h after i.p.
challenge with PBS or 2 mg/g of undigested DNA. Neutrophil numbers in PEC were determined by
multiplying the total cell numbers by the percentage of Ly-6G+ cells.
We then sought to determine if DNA-induced TNFa influences overall endothelial activation,
since the expression of many adhesion molecules, such as VCAM1, is indirectly promoted by
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proinflammatory cytokines. Using cycloheximide, a classic inhibitor of protein translation, we first
clarified what portion of DNA-induced VCAM1 expression is from direct sensing of DNA and
what part is from secondary indirect activation, requiring de novo protein synthesis. After 3
hours of DNA stimulation, VCAM1 expression, in the presence or absence of cycloheximide,
was approximately equal (Figure 4d). However, after 12 hours of DNA stimulation, VCAM1
expression in the presence of cycloheximide was reduced to the level in unstimulated cells,
whereas expression in the absence of cycloheximide remained high (Figure 4d). These data
suggested that at an early time point, most of the measured VCAM1 expression was from direct
sensing of DNA by endothelial cells, and that at later time points, VCAM1 expression was
sustained by a secondary mechanism which required protein synthesis. Given the secretion of
TNFa in response to DNA stimulation, we utilized a TNFa neutralizing antibody to investigate
whether this secondary mechanism for sustained VCAM1 expression was due to the paracrine
actions of TNFa. After 3 hours of DNA stimulation, VCAM1 expression, in the presence or
absence of TNFa neutralizing antibody, was nearly similar (Figure 4d). In contrast, at 12 hours,
VCAM1 expression in the presence of TNFa neutralizing antibody was curtailed to the level in
unstimulated cells, suggesting that DNA-induced TNFa is required for sustained secondary
activation of the endothelium.
2.3.5 DNA-induced acute inflammation is dependent on TNFa
To evaluate the in vivo role of TNFca in acute inflammation triggered by DNA, we developed
an in vivo model of DNA-induced inflammation. We injected complexed-DNA, as well as
complexed-DNAse1 digested DNA, intraperitoneally (i.p.) into mice. After 16 hours, mice
injected with undigested DNA had abundant neutrophils in their abdominal cavities (Figure 4e),
indicated by the staining of peritoneal lavage cells with the neutrophil marker Ly-6G. However,
mice injected with DNAse1 digested DNA had minimal neutrophil infiltration (Figure 4e), in
agreement with prior reports suggesting that DNAse digestion renders DNA inert to innate
immune system. Mice deficient in the TNFa receptor (TNFR1-/-) also had significantly reduced
neutrophil accumulation when injected with undigested DNA, compared to abundant neutrophils
in TNFR1+/+ mice treated with undigested DNA (Figure 4f). Taken together, these results
demonstrate that detection of DNA triggers acute inflammation dependent on TNFa signaling.
2.4 Discussion
The endothelium is exposed to DNA during infection and tissue injury. In this chapter, we
identify the signaling cascade induced by DNA for activating endothelial cells to express
adhesion molecules and facilitate leukocyte recruitment. Our results indicate that DNA activates
NFKB, JNK, and p38 MAPK pathways, for expression of endothelial adhesion molecules.
Furthermore, our study determined that DNA sensing leads to the robust secretion of TNFa,
which acts as a paracrine mediator for the sustained secondary activation of the endothelium.
We also demonstrated the requirement for TNFa signaling in establishing an acute inflammatory
response to DNA in vivo.
DNA stimulation resulted in the activation of NFKB, JNK, and p38 MAPK in endothelial cells.
Although DNA induced NFKB activation has been previously reported in literature [12, 21], it is
unclear whether DNA directly activates NFKB or indirectly through a secondary mediator [22].
We observed that early in infection, DNA directly activated NFKB, and this activation is limited
by pharmacologic inhibition of NFKB but not by cycloheximide, suggesting that de novo protein
synthesis is not required. Similarly, our results suggest that DNA directly activates JNK and p38
MAPK as well. The activation of MAPK pathways by DNA is relatively unexplored. While some
reports show no activation of MAPK or NFKB in response to DNA [23], others demonstrate the
contrary [22, 24]. Recent investigations have suggested this discrepancy in NFKB activation can
be attributed to the use of different DNA ligands, stimulating different receptors [22, 24]. We
demonstrated that the DNA ligand poly(dA:dT) directly activates JNK and p38 pathways by
potentially the same receptor that activates NFKB.
TNFa and IL1P are potent proinflammatory cytokines involved in the expression of
endothelial adhesion molecules [5]. The molecular pathways involved in DNA-induced IL1
secretion have been recently established [8, 9]. DNA activates the inflammasome pathway,
which leads to maturation and secretion of pro-IL1P. In contrast, the mechanism by which DNA
induces formation of TNFa and its role in DNA-mediated inflammation is relatively unexplored.
In this report, we established that DNA sensing by endothelial cells leads to potent expression
and secretion of TNFa. This agrees with other reports in which undigested mammalian DNA
induced TNFa in DNase II deficient macrophages [25], and enhanced expression of TNFa in
DNA stimulated hepatocytes [26]. We also identified that DNA-mediated TNFa formation was
abrogated in MEFs deficient in kinases necessary for NFKB and IRF3 activation. LPS-induced
TNFca secretion has also been shown to require both NFKB and IRF3 [27, 28]. We further
demonstrated that DNA-induced TNFa lead to the sustained activation of the endothelium, and
TNFa signaling was required for establishing an acute inflammatory response to DNA sensing
in vivo. It remains to be identified, the critical cell types required for sensing DNA and secreting
TNFa in the in vivo model of acute inflammation.
DNA-induced endothelial activation has several physiological implications. DNA viruses
such as cytomegalovirus (CMV) are known to infect endothelial cells [4], and their infection has
been associated with up regulation of adhesion molecules [29-30]. These viruses are also
investigated for their possible role in initiating atherosclerosis and inflammatory responses
resulting in vascular injury [31]. It remains to be determined if DNA-sensing by endothelial cells
plays a role in the etiology of cardiovascular diseases. Another area that requires consideration
of DNA-induced immune responses is gene therapy. The endothelium is an attractive target for
gene therapy because of its easy accessibility, and its importance in pathophysiological
conditions. Various strategies are directed towards designing appropriate gene therapy vectors
that minimize activation of the endothelium [32]. Perhaps the gene therapy approaches should
also take into account DNA-induced immune responses for achieving full therapeutic efficacy.
2.5 Materials and Methods
Materials
Dulbecco's Modified Eagle Medium (DMEM), penicillin-streptomycin, and fetal bovine serum
(FBS) were acquired from Invitrogen Life Technologies (Carlsbad, CA). Pyrrolidine
dithiocarbamate (PDTC), SP600125, SB202190 were obtained from Tocris bioscience (Ellisville,
MO). Synthetic polydeoxynucleotide, poly(dA-dT):poly(dA-dT) dsDNA, was purchased from
Amersham Biosciences. MCDB-131-complete medium was obtained from VEC Technologies
(Rensselaer, NY). Rat tumor necrosis factor-a (TNFa) was purchased from R&D Systems
(Minneapolis, MN).
Transfection of endothelial cells
Primary rat heart microvessel endothelial cells (RHMECs) were acquired from VEC
Technologies and maintained in MCDB-131 medium supplemented with 10% FBS, 10 ng/ml
EGF, 1 pg/ml hydrocortisone, 200 pg/ml EndoGro, 90 pg/ml heparin, and 1% antimycotic
solution. For transfections, RHMECs were switched to DMEM media supplemented with 10%
FBS, and 2% penicillin-streptomycin. DNA transfections were performed by using Lipofectamine
LTX (Invitrogen) at a ratio of 1.5:1 (volume/weight) with DNA as per manufacturer's protocol.
For experiments involving the use of inhibitors, cells were pretreated with PDTC (5 pg/ml),
SP600125 (20 pM), or SB202190 (10 pM) in DMEM for 1 h before dsDNA stimulation and
during stimulation. For some experiments, RHMECs were pretreated with a TNFa neutralizing
antibody (2 mg/ml; R&D Systems), or cycloheximide (20 mg/ml; Sigma Alrich) for 1 hour before
DNA stimulation and during stimulation.
Real time polymerase chain reaction
RNA was extracted from cells using nucleospin RNA II kit (Macherey-Nagel Inc., Bethlehem,
PA) according to the manufacturer's instructions. Quantitative Reverse Transcription PCR was
performed using the Superscript Ill two-Step qRT-PCR kit purchased from Invitrogen (Carlsbad,
CA). 500 ng of cellular RNA was reverse transcribed according to the manufacturer's directions.
Real-time quantitative PCR was performed using the Stratagene (La Jolla, CA) MX5000P
QPCR system. Each reaction was carried out with 10 ng cDNA and 0.6 pM primers. During
amplification, the cycling temperatures were 950 C for 15 seconds, 570 C for 1 minute and 720 C
for 30 seconds. The following primers were used for amplifying DNA: E-Selectin forward primer:
CAACACATCCTGCAGTGGTC; E-Selectin reverse primer: AGCTGAAGGAGCAGGATGAA;
ICAM1 forward primer: CCTCTTGCGAAGACGA GAAC; ICAM1 reverse primer:
ACTCGCTCTGGGAACGAATA; VCAM1 forward primer: TGAAGGGGCTACATCCACAC;
VCAM1 reverse primer: GACCGTGCAGT TGACAGTGA; TNFa forward primer:
GTCTGTGCCTCAGCCTCTTC; TNFa reverse primer: GCTTGGTGGTTTGCTACGAC; p-actin
forward primer: GTCGTACCACTGGCATTGTG; and p-actin reverse primer:
CTCTCAGCTGTGGTGG TGAA. By using the comparative cycle threshold method, all data
were normalized to endogenous reference gene P -actin and then compared with appropriate
controls for calculation of fold change.
TNFa ELISA
Supernatants from RHMECs and MEFs were used to determine the amount of rat TNFa and
mouse TNFa, respectively, that was secreted as measured by ELISA (R&D Systems) according
to the manufacturer's protocol.
Fluorescent Microscopy
Images were acquired using a Zeiss 200 M microscope (Carl Zeiss Inc., Thornwood, NY). The
fluorescence images were captured using a CCD camera (Carl Zeiss Inc.) and Zeiss imaging
software (Axiovision LE).
Leukocyte adhesion experiments
Peripheral blood leukocytes were purified from heparinized peripheral blood of rat using
Histopaque density gradient (Sigma) according to manufacturer's instructions. Leukocytes were
labeled with CM-Dil (2.5 pg/ml) at 370 C for 10 minutes and then added to RHMECs that were
stimulated with DNA (2 ug/ml) or TNFa (10 ng/ml) for 12 hours. Leukocytes were allowed to
adhere for 60 minutes at 370 C and then washed 3 times with PBS for removing non adhered
cells. Fluorescence images were captured and analyzed using Image J software (National
Institute of Health, Bethesda, MD) to estimate the degree of leukocyte adhesion to endothelial
cells.
Construction of NFKB reporter clone of endothelial cells
NFKB reporter plasmid consisted of multiple response elements upstream of destabilized green
fluorescent protein gene that encodes for d2EGFP reporter protein. The details of plasmid
construction are described elsewhere [33]. RHMECs (2.5 million) were electroporated with the
NFKB reporter plasmid (10 pg) using a BTX Electro Cell Manipulator 600 (Biotechnology and
Experimental Research, San Diego, CA) at 280 V and 960 pF. Stably transfected clones were
selected by addition of geneticin to a final concentration of 700 pg/ml. The clone that exhibited
maximum shift in fluorescence upon stimulation with TNFa was used in experiments.
Measurinq NFKB and MAPK activity
RHMECs were stimulated with different dose of DNA ranging from 0 to 4 pg/ml for 6 hours.
Nuclear extract was prepared from cells using Panomics Nuclear Extraction Kit (Affymetrix, Inc.,
Santa Clara, CA) as per manufacturer's protocol. Nuclear extracts were kept frozen in -800C
until further analysis. NFKB activity was determined by estimating the levels of NFKB p65 protein
in the nuclear extract using ELISA kit (TransFactor NFKB p65 kit, Clontech, Mountain View, CA)
according to manufacturer's instruction. Samples were normalized by total protein concentration
of the nuclear extract, determined by Bradford reagent.
RHMECs were stimulated with DNA (2 pg/ml) for 6 hours in 96 well plate. Phosphorylated
protein levels of JNK, p38 MAPK, and ERK1/2 were determined using cell based ELISA kit
(RayBio Cell-Based ERK1/2 ELISA Sampler Kit, Ray Biotech Inc., Norcross, GA) as per
manufacturer's instructions.
Animals
C57BL/6 and TNFR1-/- mice were purchased from Jackson Laboratory. All animal protocols
were approved by Massachusetts General Hospital Subcommittee on Research Animal Care.
DNA-induced inflammation
DNA was complexed with LyoVec transfection reagent according to the manufacturer's protocol
(Invivogen). DNAse I digested DNA was prepared by treating 100 mg of DNA with 5U of DNAse
I (Ambion) at 37C for 30 minutes. DNAse was then heat inactivated, and the digested DNA was
complexed with LyoVec. Mice were injected intraperitoneally with DNA (2 mg/kg) in .1 ml PBS,
DNAse digested DNA (2 mg/kg) in .1 mL PBS, 5U of heat inactivated DNAse in .1 mL PBS, or
PBS alone. At 16 hours after challenge, the numbers of neutrophils (Ly-6G+) in the peritoneum
were evaluated as previously described [34].
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Chapter 3
DNA-triggered Innate Immune Responses are Propagated by Gap Junction
Communication
3.1 Summary
Cells respond to infection by sensing pathogens and communicating danger signals to non-
infected neighbors; however little is known about this complex spatiotemporal process. Here we
show that activation of the innate immune system by dsDNA triggers intercellular
communication through a gap junction-dependent signaling pathway, recruiting colonies of cells
to collectively secrete antiviral and inflammatory cytokines for the propagation of danger signals
across the tissue at-large. Using live cell imaging of a stable IRF3-sensitive GFP reporter, we
demonstrate that dsDNA sensing leads to multi-cellular colonies of IRF3-activated cells that
express the majority of secreted cytokines, including IFNs and TNFa. Inhibiting gap junctions
decreases dsDNA-induced IRF3 activation, cytokine production, and the resulting tissue-wide
antiviral state, indicating that this immune response propagation pathway lies upstream of the
paracrine action of secreted cytokines and may represent a host-derived mechanism for
evading viral anti-interferon strategies.
3.2 Introduction
The ability of the innate immune system to propagate antiviral and inflammatory signals from
the local cellular microenvironment to the tissue at-large is critical for survival [1]. At the onset of
a viral infection, individual cells sense invading pathogens and elicit innate immune responses
that spread from infected to uninfected cells, establishing an overall antiviral state [2]. Secreted
cytokines such as interferon P (IFNp) and tumor necrosis factor (TNFca) are two key mediators
of these responses [3]. To evade the host immune system, viruses have evolved strategies for
limiting the secretion of these cytokines [4]. Nevertheless, the immune system remains capable
of clearing many viral pathogens, suggesting that the host may have subsequently evolved
additional mechanisms for propagating antiviral and inflammatory signals, beyond the paracrine
action of cytokines [5].
The innate immune system uses pathogen recognition receptors to sense nucleic acids
during infection or tissue damage [6]. Pathogen-derived nucleic acids generate potent immune
responses, as they are not typically found in a host cell or in particular intracellular locations
[7,8]. Several receptors have been identified for recognizing viral RNA, and their mechanistic
details have been well studied8 . In contrast, the sensing of viral DNA and the subsequent
triggering of a host antiviral response remain poorly understood. Double stranded DNA (dsDNA)
derived from host, viral, or synthetic sources elicits a potent immune response by activating a
TLR-independent cytosolic DNA sensor [9,10], such as the recently identified DAI (DNA-
dependent activator of IFN regulatory factors) [11]. The TLR-independent pathway for dsDNA
sensing activates TBK1 and IKKc for the phosphorylation of transcription factor IRF3, which
binds to interferon-sensitive response element (ISRE) sequences, triggering the robust
production of type I interferons such as IFNs [9,12,13]. In addition to IFNp, a successful antiviral
response requires the establishment of an inflammatory state through cytokines such as
TNFa [14]. The secretion of IFNs and TNFca is thought to play an important role in propagating
antiviral innate immune responses from individual infected cells to non-infected neighbors,
priming them to resist the spread of infection [14]. However, while this communication is
commonly attributed to secreted cytokines, the spatiotemporal details remain speculative, and
the possibility of contact-mediated communication unexplored.
Cell-cell communication can be categorized by its dependency on contact. Contact-
independent signaling is ideal for long-range communication, while contact-dependent signaling
is best suited for spatially localized rapid communication [15]. Gap junction intercellular
communication represents an important class of contact-dependent signaling. Gap junctions are
assemblies of intercellular channels composed of connexin proteins (Cx) organized into two
subsets, alpha connexins (i.e. Cx43) and beta connexins (i.e. Cx32, Cx26). Connexins from
each subset oligomerize to form a hemichannel. A functional channel is formed when a
hemichannel from one subset assembles with a hemichannel of the same subset from an
adjacent cell [16]. The resulting gap junctions directly connect the cytosol of the coupled cells,
allowing the exchange of ions, nutrients, and secondary messengers for the maintenance of
tissue homeostasis [17]. In the context of innate immunity, gap junction communication has
been shown to be regulated by pathogen associated stimuli such as LPS and peptidoglycans,
and secreted proinflammatory cytokines such as TNFa, IL1p, and IFNy [18,19]. However, the
relative contributions of contact-dependent and contact-independent communication in the
establishment of host defenses have not been explored.
Given the incomplete understanding of host innate immune response propagation, we used
a stable ISRE-GFP monoclonal reporter to explore the spatiotemporal patterns of IRF3
activation in response to dsDNA stimulation, and investigated the intercellular signaling
pathways between infected and non-infected cells for establishing an antiviral state. We found
that dsDNA stimulation induced spatially heterogeneous responses characterized by the
formation of multi-cellular colonies of IRF3 activated cells that collectively expressed more than
95% of critical secreted cytokines, including IFNs and TNFa. Functional gap junctions were
necessary for the formation of these IRF3 active colonies and blocking gap junctions with
genetic specificity limited the secretion of IFNp and TNFa and the corresponding antiviral state.
Our findings describe a previously unknown intercellular signaling pathway triggered by
cytosolic dsDNA sensing and provide evidence that gap junction communication is critical for
the amplification of antiviral and inflammatory responses, prior to paracrine-mediated
propagation by cytokines.
3.3 Results
3.3.1 GFP reporters sensitive and specific for IRF3-activating stimuli
Double-stranded DNA (dsDNA) is known to stimulate the expression of genes with ISRE
consensus sequences in their promoters through activation of the IRF3 transcription factor
[9,12]. To investigate the spatiotemporal evolution of dsDNA-induced gene expression, we
created a stable monoclonal ISRE-GFP reporter cell line in a hepatocyte-derived H35 cell line
and selected clones exhibiting low baseline GFP expression in the absence of stimuli, and high
dsDNA-induced GFP expression (Fig. 1a). To characterize the reporter, we first assessed its
specificity for IRF3-dependent gene expression by exposing confluent reporter monolayers to
various immunostimulatory molecules and measuring ISRE reporter fluorescence using flow
cytometry (Fig. 1b). When reporters were exposed to synthetic B-form Poly(dA-dT):Poly(dA-dT)
(hereafter referred to as dsDNA) or dsRed plasmid DNA, total population fluorescence
increased in a dose-dependent fashion. Similarly, when cells were stimulated with
polyinosinic:polycytidylic acid (poly(1:C)), a synthetic double-stranded RNA known to activate
IRF3, dose-dependent increases in total fluorescence were also observed. In contrast, IRF3-
independent stimuli such as TLR9-dependent CpG DNA, IFNs, poly(A) ssDNA, and siRNA did
not elicit measurable increases in ISRE reporter fluorescence at any of the doses examined. As
anticipated, LPS, which classically signals through TLR4 and IRF3, failed to activate the ISRE
reporter, consistent with the fact that nonimmune cells do not express significant levels of TLR4
(confirmed by qPCR - data not shown). To verify that the ISRE reporters retained previously
reported dsDNA-induced responses [9], we confirmed the expression of IFNs and TNFa after
12 hours of dsDNA stimulation (Fig. 1c). Taken together, these results demonstrate that the
ISRE reporters are sensitive for both dsDNA and Poly(1:C) stimulation, and specific for IRF3-
activating stimuli.
When we examined the distribution of ISRE reporter fluorescence after dsDNA stimulation
by flow cytometry, we found that increasing doses of dsDNA resulted in increasing numbers of
activated cells rather than increasing levels of activation in all cells, indicating that the cellular
response was heterogeneous (Fig. 1d,e). Therefore, we used fluorescence microscopy to
examine the distribution of dsDNA-induced GFP expression and discovered a striking spatial
pattern. dsDNA stimulation of confluent reporter monolayers exhibited well-delineated clusters
of GFP positive cells or "colonies" in an otherwise dark background of non-activated cells.
Increasing doses of dsDNA led to increasing numbers of colonies with eventual bridging of
adjacent colonies (Fig. 1f,g). To gain further insight into colony formation, we examined the
temporal evolution of ISRE-activated colonies by monitoring GFP reporter induction with time-
lapse fluorescence microscopy and quantifying colony area using custom automated image
analysis software (Fig. 1h-j). Colony activation began 8-12 hours after dsDNA-stimulation and
grew to a steady-state size, with clearly demarcated colony borders characterized by highly
induced reporter cells inside and uninduced cells outside. These findings confirm that dsDNA
stimulation leads to spatially heterogeneous patterns of ISRE-activated colonies in an otherwise
uninduced confluent monolayer of cells. Interestingly, Poly(1:C) stimulation also led to ISRE
reporter activation, however the response was spatially homogeneous across the reporter
monolayer and did not result in colony formation (data not shown).
Since dsDNA requires polyelectrolyte complexing for immunogenicity, and high molecular
weight complexes have short diffusion distances, we reasoned that dsDNA complexes land in
discrete locations within the cultured monolayer, stimulate individual dsDNA-sensing cells, and
ISRE colony-formation arises by a secondary intercellular communication signal. To clarify
which cells were directly and indirectly activated by dsDNA, ISRE reporters were stimulated with
dsDNA encoding the red fluorescent protein (dsRED). dsRED stimulation of ISRE-GFP
reporters resulted in multi-cellular ISRE reporter cell colonies surrounding individual dsRED
DNA sensing cells (Fig. 1k, see Supplementary Data Figure Si). Using the custom automated
image analysis software discussed above, we determined that the average colony was
comprised of 23.5 ISRE activated cells, of which 2.3 cells were dsRED DNA sensing cells (see
Supplementary Data Figure Sid).
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Figure S1. Localization of dsDNA in ISRE-GFP reporter monolayers. ISRE-GFP reporters were
stimulated with 2 mg/mL of complexed dsRED DNA. Cells were imaged 24 hours later using fluorescence
microscopy. (a-c) Multi-cellular colonies of activated ISRE reporter cells (green) were observed
surrounding 1-2 dsDNA sensing cells (red). Three set of representative 1OX fluorescence images of (a)
dsRED, (b) GFP, and (c) overlay are shown. (d) Custom automated image analysis software was used to
generate image corresponding iso-intensity contour maps for colony size identification. Data represent
mean and +sd of ten randomly selected 1OX images from three independent experiments.
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3.3.2 Spatiotemporal IRF3-mediated gene expression
We next sought to determine whether the colonies of GFP+ ISRE reporters had functional
significance by examining their gene expression profiles and comparing with their GFP-
neighbors. Confluent monolayers of reporters were stimulated with dsDNA for 12 hours, sorted
into GFP+ and GFP- populations by FACS, and examined for expression of IRF3-mediated
genes by qPCR (Fig. 2a). GFP+ cells represented less than 8% of the total population, yet
expressed more than 95% of secreted cytokines and chemokines including IFNP, TNFa, and
IP10 (Fig. 2b). In contrast, expression of IFNp-inducible genes, with direct antiviral properties,
such as PKR and OAS1, did not differ significantly between the two populations (Fig. 2c). Given
the commonly held view that antiviral genes are expressed in response to the paracrine action
of IFNP, these results suggest that dsDNA sensing in individual cells leads to IRF3-activation in
colonies of cells that collectively secrete cytokines, such as IFN and TNFa, to establish an
antiviral state across the broader population.
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Figure 2 Spatial gene profiling triggered by dsDNA stimulation (a) ISRE-GFP reporter cells were
stimulated with 4 sg/mL dsDNA for 12 hours and then sorted by FACS into GFP positive (+) and GFP
negative (-) cells. (b) Expression of IFNs, TNFa, and IP10 in GFP sorted (positive and negative) and
unsorted cells, as assessed by qPCR. (c) Expression of IFNp-mediated antiviral genes, PKR and OAS1.
Data were normalized to control mock dsDNA stimulated cells.
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3.3.3 IRF3 activation by contact-dependent intercellular communication
We hypothesized that IRF3-activated colony formation required secondary intercellular
communication from dsDNA-sensing cells. To test this hypothesis, we developed a transplant
co-culture system using dsDNA-stimulated non-reporter cells as donors and unstimulated ISRE
reporters as recipients. Donor cells were stimulated with dsDNA for 6 hours, trypsinized,
thoroughly washed, and transplanted onto recipient ISRE reporters that had never been
exposed to dsDNA (Fig. 3a). After 18 hours of co-culture, ISRE reporters were activated in
small colonies surrounding donor cells (Fig. 3b,c). In contrast, no IRF3 activity was observed in
the reporters when mock dsDNA stimulated non-reporter cells were transplanted (Fig. 3c).
Interestingly, not all dsDNA-stimulated cells were able to activate IRF3 in neighboring reporters.
dsDNA-stimulated human cervical cancer cells (HeLa) and mouse neuroblastoma cells (N2A)
were unable to activate IRF3 in the reporters (Fig. 3b,c), demonstrating that the phenomenon is
cell-type specific and not an artifact of nonspecific dsDNA carryover from the donor cells. Donor
cells were also stimulated with dsRed DNA, in order to identify them within the co-culture, and to
confirm that they make contact and adhere to the reporter cells (see Supplementary Data Figure
S4). To investigate whether direct cell contact was necessary for this dsDNA-induced secondary
intercellular communication, we cultured dsDNA-stimulated donors and ISRE reporter recipients
on opposite surfaces of a microfluidic parallel plate bioreactor (separation gap of -50 tm, see
Supplementary Data Figure S5). Negligible reporter induction was observed, suggesting that
dsDNA-induced intercellular communication is contact-dependent. Taken together, these data
suggest that dsDNA stimulation induces contact-dependent intercellular communication from
dsDNA sensing cells to their unstimulated neighbors, propagating an IRF3-activating signal and
amplifying IRF3-dependent gene expression.
To further clarify the pathways connecting donor dsDNA sensing and recipient IRF3
activation, we used genetic knockout mouse embryonic fibroblasts (MEFs) to determine the
necessity of critical proteins. Wildtype MEF donors stimulated with dsDNA activated ISRE in
reporter recipients (Fig. 3d,e). In addition, MEFs deficient in both TBK1 and IKKE (Tbkl-/-Ikbke-
/-), kinases necessary for IRF3 activation, also activated ISRE in reporter cells (Fig. 3d,e).
Similarly, dsDNA-stimulated MEFs deficient in both IKKa and IKKp (IKKa-/-lKKp -/-), kinases
essential for NFKB activation, also activated ISRE in reporter cells (Fig. 3d,e). MEFs deficient in
both MyD88 and TRIF (MyD88-/-TRIF-/-) were also able to activate ISRE reporter recipients
(data not shown). Together, these data suggest that dsDNA-induced intercellular
communication is TLR-independent and occurs upstream of both IRF3 and NFKB activation in
dsDNA sensing cells.
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Figure 3 IRF3 activated colonies form by contact dependent cell-cell communication (a) Transplant
co-culture system schematic. Non-ISRE reporter donor cells were stimulated with 10 [tg/mL dsDNA for 6
hours. The donors were washed and trypsinized, and a subpopulation was co-cultured with ISRE-GFP
reporter recipient cells. The co-culture was assayed 18 hours later by fluorescence microscopy and flow
cytometry. (b,d) Representative 1oX fluorescence images of reporter recipient cells co-cultured with
various dsDNA-stimulated donor cells. (c,e) Relative GFP activity quantified by image analysis. Data
represent mean and +sd of five representative images from three independent experiments.
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Figure S4. Identification of N2A donor cells in the transplant co-culture system. Wildtype N2A (N2A
WT) or Cx32-expressing N2A (N2A Cx32) were stimulated with 10 mg/mL dsRED DNA for 6 hours,
washed, trypsinized, and co-cultured with H35 ISRE-GFP reporter cells. The co-culture was assayed 18
hours later by fluorescence microscopy in order to indentify donor cells within the co-culture.
Representative 1OX fluorescence images of dsRED-stimulated (a) N2A WT or (b) N2A Cx32, co-cultured
with H35 ISRE-GFP reporters.
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Figure S5. Microfluidic parallel plate bioreactor experiment for evaluating cell contact
dependency. Schematic of microfluidic device. dsDNA-stimulated non-reporter cells were seeded on the
floor of the single channel device through input channel 1. After 2 hours, the device was flipped upside
down, and H35 ISRE-reporter cells were seeded on the ceiling of the device through input channel 2.
Both input and output channels were clamped off for 18 hours and then imaged for reporter activity.
3.3.4 Gap junctions are necessary for amplified IRF3 activation
Gap junction communication enables the rapid, localized exchange of information between
cells linked through connexin protein channels [16]. To determine the necessity of gap junctions
in the dsDNA-induced intercellular communication, we pretreated ISRE reporters with 18p-
glycyrrhetinic acid (18pGA), a molecular inhibitor of gap junctions [20], prior to dsDNA
stimulation. Compared to vehicle controls, pretreatment with 18pGA dramatically reduced
colony size, resulting in mostly single cell reporter activation (Fig. 4a). Images were quantified
by creating iso-intensity contour maps, and calculating the average size per colony for each
colony present in the images (Fig. 4b). The average size of dsDNA-induced ISRE-activated
colonies was reduced by more than 10-fold with 180GA treatment compared to no 18pGA
treatment. More than 75% of all colonies formed in the presence of 18pGA contained fewer than
3 cells, whereas more than 90% of all colonies formed in the absence 18pGA contained more
than 3 cells (Fig. 4c). In addition, the overall number of ISRE activated-GFP positive cells was
decreased from 38% to 5%, as a result of gap junction blockage (Fig. 4d). These results were
further validated by connexin 32 (Cx32) knockdown analysis, using Cx32-targeted siRNA (see
Supplementary Data Figure S3). Compared to control siRNA, Cx32 siRNA knockdown resulted
in a significant decrease in both the size of dsDNA-induced ISRE active colonies, and in the
overall number of dsDNA-induced GFP positive reporters. More than 70% of all colonies formed
in the presence of Cx32 knockdown contained fewer than 3 cells, whereas more than 85% of all
.. ..............................................................................
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colonies formed in the presence of control knockdown contained more than 3 cells (see
Supplementary Data Figure S3).
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Figure 4 dsDNA-induced IRF3 amplification requires gap junctions (a) ISRE-GFP reporters were
stimulated with 4 [tg/mL dsDNA and GFP activity was assayed 18 hours later. (a) Representative 5X
fluorescence images of dsDNA-stimulated GFP reporters and (b) corresponding contour maps outlining
automated colony identification, in the presence (left) or absence (right) of 25 [M 18pGA. (c) Percentage
of dsDNA-induced colonies less than 3 cells and more than 3 cells, in the presence (black) or absence
(grey) of 18pGA. (d) dsDNA-stimulated ISRE-GFP reporter activity with or without 18-p-GA treatment, as
determined by FACS. (e-h) Transplant co-culture experiments with genetically modified cells. Donor HeLa
or N2A cells (WT, Cx26 expressing, Cx32 expressing, or Cx43 expressing) were stimulated with 10
[tg/mL dsDNA for 6 hours, and then transplanted onto recipient ISRE-GFP reporters for 18 hours. (e)
Representative 5X fluorescence images of dsDNA-stimulated HeLa WT, HeLa Cx26, HeLa Cx32, and
HeLa Cx43 cells co-cultured with GFP reporters. (g) ISRE-GFP activity in HeLa/reporter co-cultures, as
determined by FACS. (f) Representative 5X fluorescence images of dsDNA-stimulated N2A WT, N2A
Cx26, N2A Cx32, and N2A Cx43 cells co-cultured with GFP reporters. (h) ISRE-GFP activity in
N2Alreporter co-cultures, as determined by FACS.
The utility of chemical gap junction inhibitors such as 18pGA, is limited because of their
nonspecific side effects and unknown mechanism of action [21]. Therefore, to definitively
demonstrate the necessity of gap junction communication for the propagation of IRF3 activity,
.. .. ... . . ...... ..
we used the transplant co-culture system with genetically modified cell lines. HeLa and N2A cell
lines have been historically shown to be gap junction and connexin deficient [21, 22]. We
obtained modified monoclonal HeLa and N2A cells stably transfected with individual connexin
transgenes (Cx26, Cx32, or Cx43), thereby reconstituting connexin expression and gap junction
communication [21, 22]. PCR analysis was performed to verify appropriate connexin expression
in all HeLa and N2A cells (data not shown). PCR analysis showed that ISRE reporters express
only connexin 32, of the P-subset, and therefore only form functional gap junction channels with
other cells expressing P connexins 26 or 32. When wildtype and Cx43-expressing HeLa and
N2A cells were stimulated with dsDNA, minimal ISRE reporter activation was measured (HeLa
WT: 0.5%, N2A WT: 1.0%, HeLa Cx43: 2%, N2A Cx43: 1.5%), suggesting a lack of intercellular
communication (Fig. 4e-h). However, when Cx26 and Cx32 expressing cells were stimulated
with dsDNA, significant ISRE reporter activation was measured (Fig. 4e,f), with 63% of
reporters activated by Cx32-expressing HeLa cells and 23% by Cx32-expressing N2A cells
(Fig. 4g,h). These data suggest that functional gap junction channels are necessary for dsDNA-
induced intercellular communication and for amplifying IRF3 activation. To further generalize the
utility of gap junctions for amplifying IRF3 activation in other cell types, we constructed another
ISRE-GFP reporter in a stromal hepatic stellate cell line (HSC). When the HSC ISRE-GFP
reporters were stimulated with dsDNA, they were able to form multi-cellular colonies of IRF3
activated reporters in a gap junction dependent manner (see Supplementary Data Figure S2).
4  3 b sConoACx32
E
I
'01
,iRCNAcloy > cnscloyslNANiRC-3
CC2 Coonrrol
C d
100
40
90 30 4
9- M
20 0
3 c" ckv 3 Oetefn siRNA- sgRNA-Cx32
Control
OURNAtx32 *%*RNA Cwmc
Figure S3. Loss of function analysis by siRNA knockdown of connexin 32 (Cx32). (a) Inhibition of
Cx32 mRNA by small interference RNAs (siRNAs). Pooled siRNA targeting against rat Cx32 (siRNA-
Cx32) mRNA and control siRNA (siRNA-Control) were transfected into H35 ISRE-GFP reporter cells.
Cx32 and b-actin mRNA levels were evaluated by quantitative RT-PCR 36 hours after transient
transfection. (b) Effect of Cx32 knockdown on response to dsDNA. ISRE-GFP reporter cells were
transfected with siRNA-Cx32 or siRNA-Control for 36 hours, and then stimulated with dsDNA (4 mg/mL)
for 16 hours. Representative 1OX fluorescence images of ISRE-GFP reporter pretreated with siRNA-
Control (left) or siRNA-Cx32 (right), and then stimulated with dsDNA. (c) Custom image analysis software
was used to generate contour maps for automated colony identification. Percentage of dsDNA-induced
colonies less than 3 cells and more than 3 cells, with siRNA-Control (grey) or siRNA-Cx32 (black)
pretreatment. (d) Overall percentage of dsDNA activated ISRE-GFP reporters with siRNA-Control or
siRNA-Cx32 treatment, as measured by flow cytometry.
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Figure S2. HSC ISRE-GFP reporters generalize dsDNA-induced intercellular communication to
stromal cells that utilize Cx43 gap junctions. (a) HSC ISRE reporters were stimulated with increasing
doses of dsDNA (2, 4, and 8 mg/mL) and imaged by fluorescence microscopy after 24 hours.
Representative 1OX fluorescence images HSC ISRE reporters stimulated with dsDNA. (b,c) Transplant
co-culture system. Wildtype HeLa or Cx43 expressing HeLa were stimulated with 10 mg/mL dsDNA for 6
hours, washed, trypsinized, and co-cultured with HSC ISRE-GFP reporter cells. The co-culture was
assayed 18 hours later by fluorescence microscopy and flow cytometry. (b) Representative 1oX
fluorescence images of dsDNA-stimulated wildtype HeLa or Cx43 expressing HeLa, co-cultured with HSC
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ISRE-GFP reporters. (c) Relative ISRE-GFP activity quantified by flow cytometry. Data represent mean
and +sd of five representative images from there independent experiments.
3.3.5 Propagation of antiviral and inflammatory responses by -ap junctions
To investigate the physiological significance of gap junction-mediated amplification of IRF3
activity, we disrupted gap junctions and examined the ability of cells to mount innate immune
responses. When ISRE reporters were pretreated with 18pGA and stimulated with dsDNA, they
expressed significantly lower levels of critical antiviral cytokines in comparison to vehicle
pretreatment. After 8 hours of dsDNA stimulation, 18pGA pretreated cells expressed 6-fold less
IFNs than vehicle treated cells (Fig. 5a). Expression of the IFNp-stimulated antiviral protein
PKR was also significantly reduced by 2-fold (p<.05) in the 18pGA treated cells, compared to
vehicle treatment (Fig. 5a). Similarly, the expression of the proinflammatory cytokine, TNFa,
was reduced by 3.5-fold with gap junction inhibition (Fig. 5a).
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Figure 5 Gap junction communication results in propagation of anti-viral and inflammatory signals
in response to dsDNA stimulation (a) ISRE-GEP reporter cells were stimulated with 4 [tg/mL dsDNA for
8 hours, in the presence or absence of 180GA. Expression of IFNI3, TNFa, and PKR was assessed by
qRT-PCR. (b,c) Reporter cells (of rat lineage), expressing only connexin 32, were stimulated with 10
[tg/mL dsDNA for 6 hours, and then co-cultured with unstimulated gap junction deficient (HeLa WT) or
gap junction expressing (HeLa Cx32) human HeLa cells. (b) After 10 hours of co-culture, HeLa cells were
analyzed by qRT-PCR for IFNf3 and TNFL expression using human-specific PCR primers. (c) ELISA for
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human IFNp, secreted into co-culture supernatants by HeLa cells after 24 hours. dsDNA-stimulated
reporter co-culture with HeLa WT is indicated as GJ -, and co-culture with HeLa Cx32 is indicated as GJ+.
We further verified the role of gap junctions in innate immune responses using genetically
modified cells and the transplant co-culture system described above. Rat ISRE reporter cells,
which express only connexin 32, were stimulated with dsDNA and then co-cultured with
unstimulated human HeLa cells that either lacked gap junctions (HeLa WT) or expressed
connexin 32 gap junctions (HeLa Cx32). Recipient HeLa cells were then analyzed for cytokine
expression and secretion using human-specific PCR primers and ELISAs. When dsDNA-
stimulated reporter cells were co-cultured with HeLa Cx32 cells, HeLa IFNs and TNFa
expression was increased by 6 and 4-fold respectively, compared to co-culture with gap junction
deficient HeLa WT cells (Fig 5b). Additionally, co-culture of dsDNA-stimulated reporters with
HeLa Cx32 cells triggered a 5-fold increase in production of human IFNs compared to co-
culture with gap junction deficient HeLa WT cells (Fig. 5c). Taken together, these data suggest
that gap junctions amplify dsDNA-induced expression and secretion of IFNs and TNFa, and that
without functional gap junctions, cytokine secretion is impaired, consequently reducing the anti-
viral state in the overall population.
3.4 Discussion
Investigations of innate immune response propagation have typically focused on the
paracrine action of secreted cytokines [23]. Here we provide evidence that gap junctions amplify
innate immune responses triggered by cytosolic dsDNA. Using a stable monoclonal GFP
reporter cell line that is sensitive and specific for IRF3-mediated gene expression, we visualized
the spatiotemporal evolution of IRF3 activity in response to dsDNA stimulation. Sorting these
cells by GFP activity, we demonstrated that dsDNA stimulation of confluent cell monolayers
leads to the formation of two distinct cell populations, each with a unique gene expression
program. The IRF3-active subpopulation was spatially arranged in multi-cellular colonies that
collectively served as the dominant source of diffusible cytokines for the establishment of an
overall antiviral state. These colonies were formed by gap junction-dependent communication
between dsDNA-stimulated cells and their unstimulated neighbors. In the absence of gap
junctions, IRF3-activated colonies and total cytokine secretion were significantly diminished, as
was the resulting antiviral state. These findings place contact-dependent communication
upstream of secreted cytokines, at the earliest stages of dsDNA-induced antiviral and
inflammatory responses, and they offer gap junction communication as a novel mechanism for
amplifying dsDNA-mediated innate immunity.
Gap junctions are networks of intercellular communication channels that allow local cell
populations to rapidly share and spread signals [16]. This work has indentified a gap junction-
dependent 'recruitment' process whereby infected cells engage surrounding non-infected cells
to secrete cytokines. The molecular details of this process, its mediator, its regulation, and the
pathways that lead to its generation remain unclear and further investigation is necessary. Many
common gap junction communication mediators such as Ca+*, cAMP, and IP3, have been
implicated in the activation of inflammatory transcription factors [24, 25]. For example calcium
fluxes have been shown to activate transcription factors such as NFKB and AP1, resulting in the
expression of proinflammatory cytokines [24]. While there are links connecting gap junction
communication and inflammation, our results represent the first connection to antiviral
responses.
Secreted cytokines such as IFNs and TNFca are known to mediate the spread of antiviral
and inflammatory signals for the protection of non-infected cells against subsequent attack [3].
However, at the earliest stages of an infection, when only a limited number of cells have been
exposed to the pathogen, recruitment of neighboring non-infected cells and amplification of
cytokine production is particularly important. Paracrine feed-forward loops have been proposed
to increase the number of cytokine secreting cells beyond those initially infected, however their
significance is unclear [231. For example, dsDNA stimulation of type I interferon receptor
deficient macrophages induced similar IFN expression compared to wild-type controls,
suggesting that the IFNs paracrine loops are not necessary for amplifying IFNs secretion [10].
In this work, we show that gap junction communication provides a mechanism for single infected
cells to recruit their neighbors and amplify cytokine production prior to paracrine loops.
Compared to secreted cytokine amplification, gap junction-mediated signaling is typically faster
and therefore better suited for anticipating and preventing the rapid spread of an invading
pathogen [16].
While the existence of dsDNA-stimulated intercellular communication is clear, the precise
signaling pathway remains unknown. Evidence from transplant co-culture experiments showed
the communication does not require MyD88 or TRIF, thereby eliminating the necessity of all
known TLR pathways. Additionally, the communication was independent of TBK, IKKE, IKKa
and IKKp in the dsDNA sensing cell, demonstrating that signal generation and transmission
occur upstream of dsDNA-induced activation of NFKB- and IRF3-associated kinases. A recently
identified dsDNA-sensing molecule, DAI, was shown to bind TBK and IRF3, thereby facilitating
IRF3 phosphorylation and activation [11]. Interestingly, we found that IRF3 can be activated in
cells that were never directly exposed to dsDNA. Instead, these cells only required contact with
dsDNA-stimulated cells expressing compatible connexins. Since the dsDNA used in these
experiments (approximately 400bp) is too large to pass through gap junctions [21], our results
point to a novel mechanism for activating TBK- or IKKe-mediated phosphorylation of IRF3.
Viruses have evolved numerous strategies for silencing the defenses of infected cells. Many
viruses prevent infected cells from propagating "danger signals" by inhibiting IRF3-mediated
production and secretion of antiviral cytokines such as IFNs [4, 5]. In addition to suppressing
antiviral signals, dsDNA viruses such as vaccinia virus, also inhibit host proinflammatory
signaling by inhibiting the activation of NFKB and limiting the secretion of TNFca and ILP [26].
This work demonstrated that gap junctions enable the rapid local spread of dsDNA-induced
IRF3-activating signals from infected cells to their non-infected neighbors, potentially allowing
the escape of host "danger signals" before the virus has time to disable the antiviral program in
the infected cell. This type of immediate response has the advantage of rapidly mobilizing host
defenses against infection, resulting in the early secretion of large amounts of cytokines for
broadly inducing an antiviral state. Indeed, we found that cells deficient in gap junctions
produced significantly less IFNs and TNFa, resulting in substantial decreases in expression of
antiviral genes such as PKR. Furthermore, two dsDNA viruses that represent important causes
of human disease, herpesvirus HSV2 and human papilloma virus HPV16, were shown to
express viral proteins that close gap junctions of infected cells, suggesting that viruses have
identified gap junction communication as a critical mode for host defense signaling, and have
begun evolving strategies to inhibit these defenses [27, 28].
Mammalian cells are exposed to intracellular dsDNA during viral and intracellular bacterial
infection, during exposure to self-DNA from dying cells, and during DNA-based gene therapy [7,
9-11, 14]. The ability to increase and decrease the innate immune response in these settings
would have significant potential as a clinically relevant therapeutic. In this regard, the stable
monoclonal ISRE reporter represents an important experimental tool for discovering modulators
of the innate immune responses to these stimuli and the intercellular communication
mechanisms they utilize for propagation and amplification. However, modulation of gap junction
communication continues to be experimentally challenging. Genetic methods are certainly the
most definitive; however the degeneracy of connexin proteins required to form functional gap
junctions is such that cells deficient in individual connexins may not show significant defects due
to compensatory expression of other connexins. Future studies will be needed to evaluate the
full physiologic significance of gap junction communication in augmenting responses to dsDNA-
based stimuli.
3.5 Materials and Methods
Cells and reagents
Hepatocyte-derived H35 cells were grown in high glucose DMEM (Gibco) media, supplemented
with 10% FBS, 2% penicillin-streptomycin, and 1% MEM sodium pyruvate (100 mM) [29]. Rat
hepatic stellate cell line HSC-T6 was a gift (see Acknowledgements). Mouse embryonic
fibroblasts from wildtype C57BL/6, Myd88-/-Trif-/-, Tbk-/-Ikke-/-, Ikka-/-Ikkb-/-, and Cx43-/- knockout
mice were gifts (see Acknowledgements). Wildtype and connexin 26, 32, and 43 expressing
HeLa and N2A cells were also gifts (see Acknowledgements). All cells were maintained in the
supplemented DMEM described above. Synthetic polydeoxynucleotides, poly(dA-dT):poly(dA-
dT) dsDNA and poly(dA-dT) ssDNA, were purchased from Amersham Biosciences. Synthetic
poly(1:C) and CpG ODN were purchased from Invivogen. LPS and 18p-glycyrrhetinic acid were
purchased from Sigma Aldrich, and pdsRED was purchased from Clontech. Poly(AT) dsDNA
was labeled with CX-Rhodamine (ROX) using a Label-IT nucleic acid localization kit (Mirus Bio),
according to the manufacturers' protocol.
ISRE reporter construction and characterization
The construction and characterization of the ISRE-GFP reporter was performed as described
previously [29]. Briefly, a reporter plasmid was designed to contain multiple ISRE consensus
sequences (GAAACTGAAACT, for monitoring the binding of IRF3 [12]) upstream of a CMV
minimal promoter, upstream of an EGFP gene. Plasmid DNA was electroporated into H35 and
HSC-T6 cells and antibiotic drug selection was used to isolate stably transfected cells. Using
FACS, stably transfected cells were sorted for GFP-positive responses to Poly(AT) dsDNA, and
for GFP-negative responses in the absence of dsDNA. As a result, reporter cells with high
inducibility and low baseline expression were identified. Limited dilution was performed to obtain
single monoclonal ISRE-GFP reporter cell lines.
Quantitative RT-PCR
Total RNA was extracted from target cells using the PureLink RNA Mini kit (Invitrogen),
according to the manufacturer's protocol. Total RNA (1 [tg) was used as template to generate
cDNA by reverse-transcription. Quantitative RT-PCR was performed using the Stratagene
Mx3000P QPCR System and the SuperScript Platinum Two-Step qRT-PCR SYBR-Green kit
(Invitrogen). cDNA (50 ng) was used as template in real time- quantitative PCR with primers
pairs listed in Supplementary Table 1. Using the comparative cycle threshold (Ct) method, all
data was normalized to endogenous reference gene p-actin and then compared to appropriate
controls for calculation of fold change.
Rat IFNs Forward TGAATGGAAGGCTCAACCTC
Reverse AGTCTCATTCCACCCAGTGC
Rat TNFa Forward GTCTGTGCCTCAGCCTCTTC
Reverse GCTTGGTGGTTTGCTACGAC
Rat IP10 Forward TGTCCGCATGTTGAGATCAT
Reverse GGTCAGGAGAAACAGGGACA
Rat PKR Forward GAGACTGCCCCAGAAAACAG
Reverse ATTTGGACTCCCACGTTCAG
Rat OAS1 Forward GACGGGGAGAGTTCATCAAG
Reverse CTTGGGATCAGGATTGCTGT
Rat p-Actin Forward GTCGTACCACTGGCATTGTG
Reverse CTCTCAGCTGTGGTGGTGAA
Rat-specific primers for transplant co-culture experiments
IFNs Forward GCTATTACTGGAGGGTACAAAGG
Reverse AGAATAATGGAAAAGTTCCTGAAGA
TNFa Forward TGACCCCCATTACTCTGACC
Reverse CGTGTGTTTCTGAGCATCGT
PKR Forward CCCAATTGCCTCACAGATTT
Reverse CAGTTTTCGATGGGCTTTTC
Supplementary Table 1: Quantitative real-time PCR primers
Fluorescent microscopy and imaqe analysis
Fluorescence images were captured on a Zeiss 200 Axiovert microscope and quantified using
custom image analysis routines written in MATLAB. Briefly, images were median filtered, auto-
thresholded, and segregated to identify discreet regions representing colonies. Colony outlines
were plotted by displaying iso-intensity lines at the determined threshold level. Colony areas
were calculated, sorted and plotted versus colony index. Colony areas are expressed in terms
of cell number. Areas were converted to cell number by manually counting large multi-cell
colonies and calculating the area-to-cell ratio. In Figures 1 and 4, colonies less than 1 cell were
considered an artifact of image analysis and were ignored. In Figure 4, all colonies containing
more than 3 cells were binned together and considered multi-cellular colonies, and colonies
containing less than 3 cells were binned separately.
ELISA
Human HeLa cells (wildtype and connexin expressing) were grown to 70% confluency in 12-well
plates. DNA- stimulated rat H35 cells were co-cultured onto a sub-confluent HeLa monolayer.
After 24 hours, co-culture supernatants were used to determine the amount of human IFNs and
TNFca secreted by the HeLa cells, as measured by ELISA (PBL and R&D Systems) according to
manufacturer's instructions. Manufacturers' specifications ensured cross-reactivity between rat
and human IFNs and TNFa was less than 1%.
Transplant co-culture assay
Donor cells were transfected with 10 jtg/mL of B-form dsDNA. Six hours after transfection,
donor cells were trypsinized, washed 3 times in PBS, and counted. dsDNA-stimulated donor
cells (1x10 5 cells/mL) were transplanted onto a sub-confluent layer of recipient ISRE reporters,
maintaining a 1:10 ratio between donor and recipient cells. After 18 hours of co-culture, recipient
reporter cells were analyzed by fluorescent microscopy and FACS for ISRE activity. In some
cases, IFNs and TNFa secretion by recipient cells was measured by ELISA. Gene expression
analysis on recipient cells was performed by quantitative real time PCR, using recipient cell
species-specific primers, provided in Supplementary Table 1.
RNA Interference
Interference of rat Cx32 mRNA was performed by using Dharmacon designed ON-TARGETplus
SMARTpool siRNA duplexes targeting Cx32 (#L-091222-01). Control siRNA (siCONTROL Non-
targeting siRNA#1) was also purchased from Dharmacon. H35 ISRE-GFP reporters were
transfected with 100 nM siRNA using Lipofectamine 2000 (Invitrogen), according to the
manufacturers' protocol. At 36 hours post siRNA transfection, cells were stimulated with dsDNA
for further experiments. Knockdown of Cx32 mRNA was verified by quantitative RT-PCR (see
Supplementary Data).
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Chapter 4
Identification of a Gap Junction Communication Pathway for Preventing Drug-induced
Liver Failure and Sterile Inflammation
4.1 Summary
At the onset of sterile injury, damaged cells stimulate potent inflammatory responses that
amplify the overall injury and contribute to organ dysfunction and disease, however little is
known about how this process unfolds [1, 2]. An important clinical example of sterile injury is
drug-induced liver injury, the most common cause of acute liver failure and a significant public
health crisis [3]. Here we show that drug-induced liver injury is dependent on gap junction
communication to amplify sterile inflammatory signals generated in response to the initial toxic
injury. Mice deficient in hepatic gap junction protein connexin 32 (Cx32) were protected against
liver damage, inflammation, and death in response to hepatotoxic drug-induced injury.
Administration of these drugs resulted in the production of intracellular free radicals that
propagated through gap junctions, damaging naive surrounding cells and expanding the tissue
injury front, thereby establishing the sterile inflammatory response. Coadministration of a
selective pharmacologic Cx32 inhibitor, 2-aminoethyoxydiphenyl-borate, with the hepatotoxic
drugs significantly limited hepatocyte damage and sterile inflammation, and completely
abrogated mortality, confirming the importance of hepatic gap junction communication in sterile
injury. These findings suggest inhibition of hepatic gap junctions as a viable novel therapeutic
strategy for preventing drug hepatotoxicity and potentially other forms of sterile injury.
4.2 Introduction
Drug-induced sterile liver injury is the most common cause of acute liver failure in the
developed world, accounting for up 50% of all clinical cases [3]. It is also the leading cause for
termination of drug development and drug withdrawal from the market [4]. At the onset of drug-
induced liver failure, toxic drug metabolites lead to hepatocyte death by oxidative stress and
necrosis [5]. This results in secondary activation of the innate immune system, as the initially
distressed hepatocytes stimulate a potent sterile inflammatory response that spreads from the
local cellular microenvironment to the uninjured tissue at-large, triggering parenchymal
dysfunction and ultimately liver failure [6, 7, 8, 9]. It is currently unclear which mechanisms are
vital for communication of injury from the cellular to the tissue level.
In addition to the paracrine actions of potent proinflammatory cytokines, gap junction
intercellular communication (GJIC) pathways have recently been implicated in the propagation
of inflammatory signals [10, 11, 12]. However, the mechanisms underlying these pathways and
the relative contribution of gap junctions to sterile injury remain speculative. Gap junctions are
composed of connexin proteins (Cx) that directly connect the cytosol of coupled cells to allow
free exchange of ions and secondary messengers to locally spread cellular signals [13]. Recent
investigations in innate immunity suggest that inflammatory responses are amplified by GJIC,
raising the possibility that these communication pathways also play a significant role in
establishing drug-induced sterile liver injury [10, 11].
4.3 Results
To examine whether GJIC is involved in drug-induced sterile liver injury, we injected the
classic hepatotoxin thioacetamide (TAA) into mice deficient in Cx32 (Cx32-'-), the predominant
hepatic gap junction protein. After 24 hours, Cx32*'* mice had significantly elevated ALT/AST
levels, indicative of hepatocyte damage, while Cx32-'- mice exhibited near normal levels of
ALT/AST and significantly reduced histological evidence of damage (Fig. la-c). Proinflammatory
cytokine expression, representative of the overall sterile inflammatory response of the liver, was
also attenuated in Cx32-'- mice, as was the associated recruitment of neutrophils as assayed by
myeloperoxidase (MPO) (Fig. 1d,e). This significantly reduced hepatotoxicity resulted in 100%
survival of the Cx32-'- mice, compared to 100% mortality in Cx32'* (Fig. 1f). We further
demonstrated that this protection against TAA hepatotoxicity was not a result of defective drug
metabolism in the liver by showing that serum concentrations of TAA and its toxic metabolite
were the same in Cx32*'* and Cx32-'~ mice, as was cytochrome P450 and GST activity
(Supplementary Fig. 1,2).
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Figure 1. Thioacetamide-mediated liver injury is dependent on connexin 32. (a,b) Significantly lower
serum transaminase levels in Cx32-/- compared with Cx32+/+ mice 24 hours after treatment with a single
sub-lethal dose of TAA (200 mg/kg). (c) Less liver hemorrhaging, necrosis, and acute inflammation in
Cx32-/- mice compared with Cx32+/+ mice 24 hours after TAA treatment (H&E staining; original
magnification 1OX; scale bar = 400 [tm). (d) Increase in total liver TNF-a, pro-IL-1p, IL-6, and CCL5
transcripts, as measured by Q-PCR, in Cx32+/+ mice 12 hours after TAA, compared to Cx32-/- mice. (e)
Liver tissue myeloperoxidase activity (MPO) in Cx32+/+ and Cx32-/- mice 24 hours after treatment with
TAA. (f) Kaplan-Meier survival curve for Cx32+/+ and Cx32-/- mice over 30 days after a single lethal dose
of 500 mg/kg TAA (Cx32+/+ and Cx32-/-: n=12).
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Supplementary Figure 1. Deficiency in Cx32 does not affect xenobiotic metabolism. HPLC analysis was
performed to demonstrate that the protection against TAA hepatotoxicity in Cx32-/- mice was not a result
of defective drug metabolism in the liver. A reverse-phase HPLC assay was used to quantify the serum
concentrations of TAA and its toxic metabolite, TASO, in Cx32+/+ and Cx32-/- treated with saline or TAA
(1000 mg/kg) for 90 minutes. Standards were prepared by including known amounts of TAA and TASO in
plasma from untreated mice. Equal concentrations of TAA and TASO were found in sera of Cx32+/+ and
Cx32-/- mice treated with TAA.
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Supplementary Figure 2. Phase I and 11 drug metabolism efficiency is similar in Cx32+/+ and Cx32-/-
mice. Whole livers were excised from untreated Cx32+/+ and Cx32-/- mice and processed for analysis.
(a) Q-PCR for cytochrome P450 enzymes Cyplal, Cyp1a2, Cyp2el, Cyp2b1O, and Cyp32 reveals
approximately equal expression in Cx32+/+ and Cx32-/- livers. (b) Analysis of GST activity shows equal
activity in Cx32+/+ and Cx32-/- livers. (c) Total GSH content was found to be similar in Cx32+/+ and
Cx32-/- livers.
The dependency of drug-induced liver failure on Cx32 suggested that hepatic GJIC might be
involved in propagating sterile tissue injury via permeable mediators. Given the clear role of
ROS in drug-induced hepatotoxicity [14, 15], we investigated whether blocking hepatic gap
junctions can abrogate the propagation of free radicals during sterile injury. Livers stained ex
vivo for ROS activity revealed intense focal regions of intracellular ROS in Cx32*'* mice,
compared to minimal ROS activity in Cx32' mice treated with TAA (Fig. 2a). To determine the
dependence of drug-induced sterile injury on ROS, we utilized DMSO as a free radical
scavenger [16]. Coadministration of DMSO with TAA significantly reduced serum ALT/AST, and
prevented liver injury and inflammation in Cx32+'+ mice (Fig. 2b-c). Together, these results
suggest that ROS are essential for triggering drug-induced liver injury, and demonstrate that
deficiency in Cx32 results in markedly reduced hepatic intracellular free radical levels.
To further clarify how gap junctions regulate ROS levels in liver injury, we determined
whether hepatocytes generate ROS when challenged with hepatotoxins in vitro. Flow cytometry
analysis of hepatocyte-derived H35 cells loaded with an ROS probe and stimulated with TAA, its
reactive metabolite (TASO), or hydrogen peroxide (H202) revealed a significant increase in
mean fluorescence intensity of cells treated with H20 2 and TASO, compared to those treated
with TAA (Fig. 2d). This is consistent with prior investigations showing that cultured hepatocytes
often require pharmacological induction to metabolize drugs [17].
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Figure 2. Free radicals are propagated by connexin 32 gap junctions to amplify oxidative stress in
response to drug-induced liver injury. (a) Freshly prepared liver cryosections (7 ttm) from Cx32+/+ and
Cx32-/- mice treated with TAA (200 mg/kg) for 4 hours were stained with H2DCFH-DA, a cell permeable
ROS probe that is converted by intracellular ROS to the fluorescent derivative DCF, and analyzed by
fluorescence microscopy (original magnification 1oX; scale bar = 400 Rm; n>5). (b,c) Oxygen free radical
scavenger dimethyl sulfoxide (DMSO) was utilized to demonstrate the dependency of drug-induced
hepatotoxicity on oxidative stress. (b) Serum transaminase levels in wildtype mice 24 hours after
treatment with either saline (1 mL/kg) plus TAA (200 mg/kg) or DMSO (0.1 or 1 mL/kg) plus TAA (200
mg/kg). (c) H&E staining of livers (original magnification 1OX; scale bar = 400 stm) from wildtype mice 24
hours after treatment with saline plus TAA or DMSO plus TA. (d) Hepatocyte-derived H35 cells were
treated with 25 RM TAA, 5 [M Thioacetamide S-oxide (TASO, the reactive metabolite of TAA), or 100 [M
hydrogen peroxide (H20 2; as a positive control) for 2 hours, stained with H2DCFH-DA and analyzed by
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cytometry for determining levels of intracellular ROS. Flow cytometry distribution of H2DCFH-DA
fluorescence and mean fluorescence intensity. (e) In vitro co-culture system schematic. Wildtype HeLa
cells (HeLa WT) deficient in connexin proteins and Cx32 expressing HeLa cells (HeLa Cx32) were
stimulated with TASO (5 1AM) or H20 2 (100 RM; as a positive control) for 2 hours, in the presence or
absence of cell permeable antioxidant/free radical scavenger MnTMPyP, and plated onto H35
hepatocytes loaded with ROS probe H2DCFH-DA at a cell ratio of 2:1. Four hours later, the co-culture
was analyzed by flow cytometry for gap junction mediated transfer of ROS into H35 cells. (f) ROS levels
in H35 cells, as determined by flow cytometry.
We next devised an in vitro co-culture system to investigate whether intracellular ROS
propagate through Cx32 gap junctions. Connexin deficient HeLa cells (HeLa WT) and Cx32
expressing HeLa cells (HeLa Cx32) were stimulated with TASO in the presence or absence of a
free radical scavenger [15], and plated onto Cx32 expressing H35 hepatocytes loaded with a
ROS probe (Fig. 2e). Flow cytometry analysis of the co-culture revealed that, in the absence of
a free radical scavenger, TASO-stimulated HeLa Cx32 cells were able to propagate a ROS
inducing signal to H35 cells (Fig. 2f). In contrast, TASO-stimulated HeLa WT cells were unable
to transmit this signal to H35 cells (Fig. 2f). To determine the nature of this signal, we incubated
the HeLa cells with a free radical scavenger concurrently with TASO to remove generated free
radicals. In the presence of the scavenger, TASO-stimulated HeLa Cx32 cells were unable to
propagate the ROS inducing signal to H35 cells (Fig. 2f). These findings suggest that connexin
32 amplifies drug-induced liver failure by allowing for the propagation of free radicals from
hepatotoxin-injured cells to surrounding naive cells, thereby augmenting the downstream sterile
inflammatory response.
We then sought to explore whether pharmacological inhibition of hepatic gap junctions can
prevent drug-induced liver injury. Although many inhibitors of gap junctions lack specificity, 2-
aminoethoxydipenyl-borate (2-APB) has been shown to exclusively inhibit Cx32 gap junction
channels in vitro [18]. We first tested whether 2-APB can exogenously inhibit hepatic gap
junctions in vivo by developing a tissue version of the classic "scrape and load" gap junction
assay. In this assay, 2-APB was administered in vivo, and livers were excised for ex vivo
analysis. Liver slices were damaged locally, loaded with gap junction permeable Lucifer yellow
(LY) and impermeable Texas red-dextran (TRD), and analyzed for fluorescent dye spread.
Cx32*'* mice treated with saline showed significant gap junction connectivity, as demonstrated
by the spread of gap junction permeable LY, compared to gap junction impermeable TRD (Fig.
3a). In contrast, Cx32- mice showed minimal gap junction connectivity as did Cx32*'* mice
treated with 2-APB (Fig. 3a). Contour maps of the images, where the red and green regions
depict the spread of the TRD and LY, respectively, were used to aid in visualization and
quantification (Fig. 3a). We further demonstrated that coadministration of TAA with 2-APB in
Cx32*'* mice significantly abrogated ROS levels (Supplementary Fig. 3). These data indicate
that small molecule inhibitors of gap junctions, such as 2-APB, can be utilized to specifically
block hepatic gap junctions in vivo.
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Figure 3. Pharmacologic inhibition of hepatic gap junctions prevents drug-induced liver failure and
enhances survival. (a) A tissue version of the scrape and load test was developed to demonstrate
functional gap junction intercellular communication in liver tissue. Cx32+/+ and Cx32-/- mice were treated
with saline, 2APB (20 mg/kg), or 2APB plus TAA (200 mg/kg) for 3 hours. Livers were excised, cut into 2-
3 mm slices, and a small area of each slice was mechanically damaged with the insertion of a 27 gauge
needle coated with 0.5% Lucifer yellow (gap junction permeable) and 0.5% Texas red labeled dextran
(gap junction impermeable). Slices were washed, fixed, cryosectioned (7 tm), and analyzed by
fluorescence microscopy (n>5) and custom automated image analysis software to produce iso-intensity
contour maps outlining spread of Lucifer yellow and dextran-Texas red. (b) Serum transaminase levels
and (c) liver tissue myeloperoxidase activity (MPO) in wildtype mice 24 hours after treatment with 2APB
alone, TAA (200 mg/kg) plus vehicle, or TAA (200 mg/kg) plus 2APB (1 or 20 mg/kg). (d) H&E staining of
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livers (original magnification 1 OX; scale bar = 400 [m) from wildtype mice 24 hours after treatment with
vehicle, TAA (200 mg/kg), or TAA (200 mg/kg) plus 2APB (20 mg/kg). (e) Q-PCR for TNF-a, pro-IL-1 P, IL-
6, and CCL5 from whole livers of mice treated as described above. (f) Kaplan-Meier survival curve for
Cx32+/+ mice over 30 days after a single dose of TAA (500 mg/kg) plus vehicle, or TAA (500 mg/kg) plus
2APB (20 mg/kg). (n=10).
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Supplementary Figure 3. Coadministration of TAA with 2-APB abrogated hepatic ROS levels. Liver
cryosections from Cx32+/+ mice treated with vehicle, TAA (200 mg/kg) plus vehicle, or TAA (200 mg/kg)
plus 2APB (20 mg/kg) for 4 hours were stained with dihydroethidium, a cell permeable free radical probe
that binds nucleic DNA and becomes fluorescent when reduced, and analyzed by fluorescence
microscopy for ROS activity (n>5).
To determine whether liver injury could be reduced by inhibition of hepatic gap junctions in
vivo, we co-injected 2-APB with TAA. Coadministration of 2-APB with TAA significantly reduced
serum ALT, histological evidence of hepatic damage, and neutrophil infiltration (Fig. 3b-d).
Additionally, the sterile inflammatory response was also curtailed (Fig. 3e). We then sought to
determine whether a single administration of 2-APB concordantly with TAA could improve
survival from drug-induced liver failure. Remarkably, administration of 2-APB with TAA resulted
in 100% survival, compared to 100% mortality in mice that received TAA with vehicle (Fig. 3f).
Together, these results further confirm the importance of connexin 32 gap junctions in drug-
induced sterile liver injury, and also identify a new therapeutic strategy of specifically inhibiting
hepatic gap junctions to prevent hepatotoxicity.
In order to test the broader applicability of these findings, we used another classic
hepatotoxic drug, acetaminophen (APAP). APAP hepatotoxicity is the most common cause of
death due to acute liver failure [19]. A single dose of APAP resulted in liver failure, as indicated
by markedly elevated serum ALT and neutrophil recruitment (Fig. 4a,b). In contrast, a single
dose of 2-APB coadministered with APAP resulted in significantly reduced serum ALT levels by
270-fold, and diminished neutrophil infiltration (Fig. 4a,b). Histological evidence of hepatic
necrosis and inflammation was also substantially minimized in mice treated with 2-APB (Fig.
..... 
.. ....
...........
4c). We further demonstrated the ability of pharmacologic hepatic gap junction inhibition to
minimize APAP induced liver failure by utilizing a higher, lethal concentration of APAP
(Supplementary Fig. 4).
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Figure 4. Acetaminophen (APAP) hepatotoxicity is limited by inhibition of hepatic gap junction
communication. (a) Serum transaminase levels and (b) liver tissue myeloperoxidase activity (MPO) in
wildtype mice 16 hours after treatment with 2APB (20 mg/kg), APAP (500 mg/kg) plus vehicle, or APAP
(500 mg/kg) plus 2APB (20 mg/kg). (c) H&E staining of livers (original magnification 1oX; scale bar = 400
[tm) from wildtype mice 16 hours after treatment as described above.
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Supplementary Figure 4. Inhibition of hepatic gap junction communication limits APAP hepatotoxicity at
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lethal doses. (a) Serum transaminase levels and (b) liver tissue myeloperoxidase activity (MPO) in mice
16 hours after treatment with 2APB (20 mg/kg), APAP (750 mg/kg) plus vehicle, or APAP (750 mg/kg)
plus 2APB (20 mg/kg). (c) H&E staining of livers (original magnification 1OX; scale bar = 400 [m) from
mice 16 hours after treatment as described above.
4.4 Discussion
Our work reveals a key role for ROS in mediating gap junction dependent sterile
inflammation, and raises the possibility that cell death and injury attributed to ROS generation
can be limited by their inhibition. Blocking the amplification of sterile inflammation is a potentially
attractive strategy not only to minimize the damage associated with drug-induced hepatotoxicity,
but also to limit inflammation to tissue injury in general. These results could have significant
medical implications. Drug-induced hepatotoxicity is the most common cause of acute liver
failure, and with limited medical therapies for treatment, many cases result in liver
transplantation or death due to a sterile inflammatory response that amplifies the initial insult [3-
6]. Our findings demonstrate that drug-induced sterile liver injury is dependent on Cx32 gap
junctions and selectively blocking them with small molecules can prevent liver failure and
enhance survival. Similar therapies are currently in clinical trials for preventing life threatening
sterile inflammation due to myocardial ischemia-reperfusion injury [20]. In summary, our work
suggests that coformulation of gap junction inhibitors with hepatotoxic drugs may limit liver
failure in humans, thereby increasing the number of clinically effective drugs, maximum
allowable doses, and breadth of medical indications. These inhibitors may also have therapeutic
potential in other types of liver injury and other organ systems.
4.5 Materials and Methods
Animals and cell lines
C57BL/6 mice were purchased from Jackson Laboratory. Cx32~1 mice were a generous gift (see
Acknowledgements). All animal protocols were approved by Massachusetts General Hospital
Subcommittee on Research Animal Care. For survival experiments, animals were euthanized
when they became moribund according to the criteria of lack of response to stimuli or lack of
righting reflex. H35 hepatocyte-derived cells were maintained as previously described [21].
Connexin 26, 32, and 43 expressing HeLa cells were gifts (see Acknowledgements).
TAA-induced hepatotoxicity
TAA (Sigma Aldrich) solution was made fresh for each experiment in 0.9% saline at 20 mg/ml.
TAA was dosed at 200, 500 or 1000 mg/kg, depending on the experiment, and injected
intraperitoneally. Control mice received the appropriate volume of 0.9% saline. Animals were
euthanized by ketamine/xylazine injection at 24 hours for collection of serum and liver tissue for
qPCR, GSH/GST assay, MPO activity assay, and histology. For survival experiments, animals
were observed every 24 hours for 30 days.
APAP-induced hepatotoxicity
APAP (Sigma Aldrich) solution was made fresh for each experiment in 0.9% saline at 20 mg/ml
and heated until dissolved. APAP was dosed at 500 or 750 mg/kg, and injected intraperitoneally
after 15 hours of starvation. Animals were euthanized by ketamine/xylazine injection at 12 hours
for collection of serum, and liver tissue for MPO activity assay and histology.
2-Aminoethoxydiphenyl Borate treatment
2-APB (Sigma Aldrich) was made fresh for each experiment in DMSO as a vehicle at 200
mg/ml. 2-APB was dosed at 1 or 20 mg/kg, and coadministered concurrently with the
appropriate dose of TAA or APAP. Vehicle control mice received the appropriate volume of
DMSO with TAA or APAP.
DMSO treatment
Fresh anhydrous DMSO (Sigma Aldrich) was used for each experiment. DMSO was dosed at
0.1 or 1 ml/kg, and coadministered concurrently with 200 mg/kg TAA or saline.
Myeloperoxidase (MPO) activity assay
Mouse liver tissues were homogenized in MPO buffer (0.5% hexadecyl trimethyl ammonium
bromide, 10 mM EDTA, 50 mM Na2HPO 4, pH 5.4) using a Polytron homogenizer. Liver
homogenates were then subject to three freeze-thaw cycles and cleared by centrifugation. MPO
reaction was carried out using the Invitrogen EnzChek Myeloperoxidase Activity Assay Kit
according to the manufacturer's protocol.
Quantitative RT-PCR
Mouse liver tissues were crushed to a powder in liquid nitrogen, and total RNA was extracted
using the Invitrogen Trizol RNA extraction kit, and then purified using the RT2 qPCR-Grade RNA
Isolation Kit (SA Biosciences), according to the manufacturer's protocol. Total RNA (500 ng)
was converted into cDNA using the RT2 First Strand Kit (SA Biosciences). Quantitative RT-PCR
was performed using the Stratagene Mx3000P QPCR System and the RT2 qPCR Master Mix Kit
(SA Biosciences). Quantitative RT-PCR was performed for mRNA expression of Gapdh, TNFa,
pro-IL-1p, IL6, CCL5, Cyplal, Cyp1a2, Cyp2el, Cyp2b1O, and Cyp3a using primers designed
by SA Biosciences. Expression of Gapdh was used to standardize the samples, and the results
were expressed as a ratio relative to control.
Tissue scrape and load assay for GJIC
Mice were treated i.p. with saline, 2-APB (20 mg/kg), or 2-APB (20 mg/kg) plus TAA (200
mg/kg), and 3 hours later livers were excised and freshly sliced. A 27-gauge needle was dipped
into a solution containing 0.5% Lucifer Yellow (Invitrogen) and 0.5% 10kDa dextran-Texas Red
(Invitrogen), and the needle was used to both mechanically damage a small area of each slice
and apply the dyes. The liver slices were incubated with the dye solution for 5 minutes, rinsed in
saline, fixed in 4% paraformaldehyde for 30 minutes, frozen in OCT compound, cyro-sectioned
into 7 [tm sections, rinsed in saline, mounted, and imaged by fluorescence microscopy.
H2DCFH-DA and dihydroethidine hydrochloride (DEH) staining
Freshly cut frozen liver sections (7 iAm) were stained with 10 ,M H2DCFH-DA (Invitrogen) or 2
1IM DEH (Invitrogen) for 30 minutes at 370C, and imaged by fluorescence microscopy as
previously described [22].
Fluorescence microscopy
Fluorescence images were captured on a Zeiss 200 Axiovert microscope at a fixed exposure
and gain. Images for the tissue scrape load assay were quantified using custom image analysis
routines written in MATLAB [10]. Briefly, images were median filtered, auto-thresholded, and
segregated to identify discreet closed regions representing the spread of Lucifer Yellow dye and
dextran-Texas Red. Regional outlines were plotted as contour maps by displaying iso-intensity
lines at the determined threshold level.
Flow cytometry
Cultured H35 hepatocyte-derived cells were loaded with 10 [LM H2DCFH-DA for 30 minutes at
37'C. This cell-permeable compound is converted into a non-fluorescent product (H2DCF), and
oxidized by free radicals to the highly fluorescent dichlorofluoresceine (DCF). Cells were
washed in PBS three times, and then treated with saline, TAA (25 [M), TASO (5 1tM), or H2 0 2
(100 [tM) for 2 hours, or subject to the transplant co-culture assay. After treatment, cells were
trypsinized, washed in PBS, and analyzed by flow cytometry.
Transplant co-culture assay
Connexin 32 expressing HeLa (HeLa Cx32) and connexin 43 expressing HeLa (HeLa Cx43)
cells were stimulated with saline, TASO (5 1 !M), or H2 02 (100 AM) in suspension for 2 hours, in
the presence or absence of cell permeable anti-oxidant MnTMPyP (Calbiochem). Two hours
after treatment, HeLa cells were washed 3 times in PBS, counted, and plated onto a sub-
confluent layer of H35 cells, preloaded with H2DCFH-DA, at a cell ratio of 2:1. After 4 hours of
co-culture, cells were trypsinized and H35 cells were analyzed for ROS activity, as indicated by
H2DCFH-DA fluorescence, by flow cytometry.
HPLC-based quantification of TAA and TASO
To quantify TAA and TASO in plasma of mice, a reverse-phase HPLC assay was used, as
previously described [23]. Briefly, 7% acetonitrile, 50 mM sodium sulfate, and 50 mM potassium
phosphate buffer was used as the mobile phase. An SPS-ODS column (5 [m; Regis
Technologies) was used to separate the components at 1 ml/min. TAA was detected by UV
absorption at 212 nm, and TASO at 290 nm, using a photodiode array detector. Retention times
for TAA and TASO were approximately 4.1 and 3 min, respectively. Standards were prepared
by including known amounts of TAA and TASO in plasma from untreated mice.
Synthesis of TASO
Thioacetamide' S-Oxide (TASO) was synthesized as previously described [24]. Briefly,
thioacetamide (TAA) was dissolved in acetone and chilled to -50C. Then 30% H202 was added
rapidly, the mixture was agitated thoroughly, and stored at 40C for 24 hours until the product
crystallized. The product, TASO, was recovered by filtration and washed with 5 portions of cold
acetone. The purity was examined by HPLC, as previously described.
Analysis of GST activity and total GSH content
Mouse liver tissues were lysed in 100 mM potassium phosphate, containing 2 mM EDTA, and
total protein content was determined. Enzymatic activity toward 1-chloro-2,4-dinitrobenzene
(CNDB) (Sigma Aldrich) was assayed in a buffer containing 100 mM potassium phosphate,
0.1% Triton X-100, 1 mM glutathione and 1mM CNDB. Formation of glutathione/CNDB
conjugate was measured in a spectrophotometer at 340 nm, as an indicator of GST activity.
Total GSH content was measured using the Glutathione Assay Kit (Sigma Aldrich), as per the
manufacturer's protocol. Briefly, mouse liver tissues were lysed and total protein content was
determined. Samples were deproteinized with 5% 5-sulfosalicylic acid, and glutathione content
of the samples was assayed using a kinetic assay in which catalytic amounts of glutathione
cause a continuous reduction of 5,5'-dithiobis-(2-nitrobenzoic) acid (DTNB) to TNB. TNB was
measured colorimetrically at 412 nm, as an indicator of total GSH content.
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Chapter 5
Conclusions
5.1 Thesis Contributions
The major contribution of this thesis is the identification of a critical gap junction
communication pathway for amplifying innate immune and inflammatory responses. Gap
junction communication is typically used by cells to send signals rapidly over short length
scales. As a result, gap junction research initially focused on electrically excitable cells such as
neurons and cardiac myocytes. However, more recently, the roles for gap junctions have
expanded to include communication in the context of immunity and inflammation [33, 34]. These
new roles have generated many interesting questions: what is the significance of gap junction
communication in the response to innate immune activation, and are secreted cytokines not
already a mediator of intercellular communication for spreading immune signals during infection
or injury? We believe the work completed in this thesis proposes the following possible
explanation for why the innate immune system might have evolved such a signaling
mechanism.
When a tissue is first faced with an infection, the total number of pathogens is limited, and
the number of infected cells is small. Pathogens that infect host cells will activate intracellular
innate immune signaling pathways (i.e. the TLR or NLR pathways) and cause release of key
alarm cytokines such as IFNp, TNFa, and IL-1p. Without gap junctions, the amount of
secreted cytokine would be limited to that produced by the directly infected cells. However with
gap junctions, a significantly larger population of host cells can be recruited to contribute to the
initial secretion, thereby amplifying the cytokine response. This work shows that, depending on
the nature of the cytokine, this amplification might be as much as 100-1000 fold. Such
amplification is important since cytokines must accumulate in the extracellular space and diffuse
to transmit warning signals to distal neighbors. In the case of sterile injury, the host inflammatory
response to injury can contribute to the pathogenesis of disease, and serve as the initiator of
organ dysfunction and ultimately failure. Our work shows that, in the absence of infection, gap
junction communication pathways amplify pathologic, rather than protective, immune responses.
Blocking this pathologic inflammatory response is a potentially attractive strategy to limit the
damage of acute sterile inflammation and to stop the ongoing damage in chronic inflammation
to tissue injury. This work shows that, in the case of drug-induced sterile liver injury, selectively
blocking hepatic gap junctions with small molecules can prevent liver failure and enhance
survival. This type of gap junction inhibition strategy may also have therapeutic potential in other
forms of liver injury and other organ systems. Similar therapies are currently in clinical trials for
preventing life threatening sterile inflammation due to myocardial ischemia-reperfusion injury.
5.2 Thesis Conclusions
5.2.1 Overall
This thesis demonstrates the development of novel tools for investigating the spatiotemporal
dynamics of cellular responses, describes how these tools were utilized to discover a basic gap
junction communication pathway critical in innate immunity and inflammation
Through the use of stable GFP reporters, in vitro transplant coculture systems, and in vivo
models of infection and sterile injury, we attempted to bridge the gap between basic discovery,
at the cellular level, and application at the level of animal models. The first section describes the
development of stable GFP reporters to study the spatiotemporal activation patterns of two key
transcription factors in inflammation and innate immunity: NFKB and IRF3. Stimulation of NFkB-
GFP reporters resulted in a spatially homogeneous pattern of activation, found to be largely
mediated by the paracrine action of proinflammatory cytokine TNFa. In contrast, the activation
of IRF3 was spatially heterogeneous, leading to the formation of multicellular colonies in an
otherwise dark background of non-activated cells. The second section describes the discovery
of a gap junction intercellular communication pathway necessary for the formation of these IRF3
active colonies of cells that collectively expressed more than 95% of critical secreted cytokines,
including IFNs and TNFa. Blocking gap junctions, with genetic specificity, limited the secretion
of IFNs and TNFa and the corresponding antiviral and inflammatory state. The third section
demonstrates an application of the gap junction communication phenomenon in an animal
model of sterile injury. Drug-induced liver injury was shown to be dependent on gap junction
communication for amplifying sterile inflammatory signals. Mice deficient in hepatic gap junction
protein Cx32 were protected against liver damage, inflammation, and death in response to
hepatotoxic drug-induced injury. Coadministration of a selective pharmacologic Cx32 inhibitor
with the hepatotoxic drugs significantly limited hepatocyte damage and sterile inflammation, and
completely abrogated mortality, confirming the importance of hepatic gap junction
communication in amplifying sterile injury and providing a potential novel therapeutic strategy for
preventing drug hepatotoxicity.
The remainder of this section summaries the general conclusions drawn from each of the
individual chapters.
5.2.2 Chapter 2
In this chapter we investigated the DNA-triggered molecular signaling pathways that lead to
activation of the endothelium. We demonstrated that direct exposure to DNA induced activation
of NFKB and MAPK pathways in endothelial cells. This lead to increased expression of
endothelial adhesion molecules, ' and resulted in functional leukocyte adhesion to the
endothelium. NFKB, JNK, and p38 MAPK were critical for leukocyte adhesion, as
pharmacological inhibition resulted in decreased expression of adhesion molecules. We further
showed that detection of DNA triggers robust secretion of TNFa for sustained secondary
activation of the endothelium. Both IRF3 and NFKB were required for the production of the
TNFa, and mice deficient in the TNF receptor were unable to mount an acute inflammatory
response to dsDNA. Our findings identify NFKB and TNFa as an alternative innate immune
mechanism to the inflammasome and L1P, capable of initiating and amplifying a
proinflammatory response to DNA. This work suggests the involvement of DNA-induced
endothelial cell immune responses in host defense to infection or sterile injury.
5.2.3 Chapter 3
In this chapter we used a stable IRF3-GFP monoclonal reporter to explore the
spatiotemporal patterns of IRF3 activation in response to DNA stimulation, and investigated the
intercellular signaling pathways between infected and non-infected cells for establishing an
antiviral state. We found that DNA stimulation induced spatially heterogeneous responses
characterized by the formation of multicellular colonies of IRF3 activated cells that collectively
expressed more than 95% of critical secreted cytokines, including IFNs and TNFa. Functional
gap junctions were necessary for the formation of these IRF3 active colonies and blocking gap
junctions with genetic specificity limited the secretion of IFNP and TNFa and the corresponding
antiviral state. Our findings describe a previously unknown intercellular signaling pathway
triggered by cytosolic dsDNA sensing and provide evidence that gap junction communication is
critical for the amplification of antiviral and inflammatory responses, prior to paracrine-mediated
propagation by cytokines. This work also suggests the key role of gap junction communication
pathways in establishing immunity.
5.2.4 Chapter 4
In this chapter we showed that drug-induced liver injury is dependent on gap junction
communication to amplify sterile inflammatory signals generated in response to the initial toxic
injury. Mice deficient in hepatic gap junction protein Cx32 were protected against liver damage,
inflammation, and death in response to hepatotoxic drug-induced injury. Administration of these
drugs resulted in the production of intracellular free radicals that propagated through gap
junctions, damaging naive surrounding cells and expanding the tissue injury front, thereby
establishing the sterile inflammatory response. Coadministration of selective pharmacologic
Cx32 inhibitors with the hepatotoxic drugs significantly limited hepatocyte damage and sterile
inflammation, and completely abrogated mortality, confirming the importance of hepatic gap
junction communication in sterile injury. These findings suggest inhibition of hepatic gap
junctions as a viable novel therapeutic strategy for preventing drug hepatotoxicity and potentially
other forms of sterile injury.
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